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ABSTRACT  
Newfoundland and Labrador (NL) has the highest prevalence of type 2 diabetes in 
Canada. Rural populations often lack adequate access to primary care services, which are 
critical for providing quality diabetes care. To assess diabetes diagnosis and outcomes 
among rural and urban populations, a population-based, retrospective cohort study of 
residents NL, Canada, with diagnosed diabetes aged ≥ 20 years old, was performed using 
an administrative database. The study population included was 17,796 subjects. Diabetes 
was classified as a complex case if comorbidities were already present at diagnosis. The 
provincial mortality database was used to determine mortality. The presence of 
complications/comorbidities was derived from patient billing data collected by the 
provincial medical care plan during the study period. Patients were geo-referenced using 
6 digit postal code. Different levels of analysis were performed. Individual level analysis, 
including bivariate and multivariate analyses using STATA. Geospatial analysis 
inclduing visualization and community level analysis using ArcMap-GIS 10.2.. The 
individual-level model showed that complex cases (OR: 1.23, 95% CI: 1.19-1.28) and 
mortality (OR: 1.11, 95%CI: 1.07-1.16) were more likely in rural areas. The community-
level model found that complex cases were more likely in rural areas (b=18.09, p< .0.05), 
while no relation was found between mortality and living in remote areas (b=3.53, p= 
0.531). This project identified higher prevalence of  complex cases in rural areas. This 
study suggests geographic differences should be taken into account for making better 
health-related decisions in diabetes care and management. 
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CHAPTER 1: INTRODUCTION 
1.1 What Is Diabetes? 
Diabetes Mellitus (DM), is among the most common, costly, and preventable chronic 
diseases, results from either the cells of our body being unable to generate enough insulin 
or cannot use insulin efficiently
1
. A person with diabetes does not move glucose into the 
cells properly, which leads to its circulating in the blood causing damaging body tissues 
over time, resulting in disabling and life-threatening health complications
1
.  
Type 2-diabetes (T2 DM) is the most common type of diabetes in adult populations
2.
 The 
number of patients living with type 2 diabetes mellitus is rapidly increasing worldwide. 
This increase may be due to economic expansion, age, dietetic changes, reduced physical 
activity, and other changes in lifestyle
2
. 
1.2 Diabetes Complications 
The most severe issue related to type 2 diabetes is that many people remain unaware of 
their illness for a long time. This lack of awareness usually happens because it may take 
year for diabetic symptoms to appear or for the condition to be diagnosed, during this 
time excess blood sugar may be damaging the body. Diabetic patients usually are 
diagnosed when complications from diabetes have already developed
3
. Diabetes is a 
leading cause of several serious complications and comorbidities such as cardiovascular 
disease, blindness; kidney failure (RF), and lower-limb amputation or developing 
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infections. There are two kinds of diabetic injurious: macrovascular comorbidites 
(coronary artery disease, peripheral arterial disease and stroke) and microvascular 
comorbidities (diabetic nephropathy, neuropathy and retinopathy)
 2, 3
.  
1.2.1 Microvascular Complications of Diabetes 
Diabetic retinopathy can be considered one of the most common microvascular 
complications of diabetes that may develop as much as seven years before the diagnosis 
of T2 DM
4, 5
. It is the reason for almost 10,000 new cases of blindness every year, in the 
United States alone
4
. 
Diabetic nephropathy is considered one of the main causes of renal failure. The 
previous studies showed that 7% of patients with type 2-diabetes might already have 
microalbuminuria, a marker for kidney disease, at the time of diagnosis with diabetes
4, 5
. 
Diabetic neuropathy is recognized by the American Diabetes Association (ADA) as ―the 
presence of symptoms and signs of peripheral nerve dysfunction in people with diabetes 
after the exclusion of other causes.‖4. 
Diabetic foot: diabetic patients may develop damage to nerves and blood vessels, which 
lead to some different foot problems. These problems result in infection and ulceration, 
which increase a person‘s risk of amputation4, 6. 
Alzheimer's disease: New research defined a direct relationship between sugar 
imbalance and Alzheimer‘s disease (AD) 7,8,9. Type 2-diabetes doubled the risk of a 
patient having dementia and patients on insulin had four times the risk
9,10,11
. A study by 
3 
 
Hisayama in 1995
8
 found that the relative risk (RR) of Alzheimer‘s disease in diabetic 
patients was 2.18 (95%CI: 1.97-4.9) and 2.77 of vascular dementia (95%CI: 2.59-2.97)
8
. 
An advanced study from the same study group (2011) showed that the RR of Alzheimer‘s 
disease was 2.05 (95%CI: 1.18-3.57) in diabetic patients and 1.82 for vascular dementia 
(95%CI: 1.89-3.71)
9
. The Rochester study in 1997
10
 reported differences in the risk of 
Alzheimer‘s disease based on gender. This study found that the RR for AD was 2.27 for 
men (95%CI: 1.55-3.31) and 1.37 for women (95%CI: 1.94-2.01)
10
. The study by 
Rotterdam in 1999 showed that the RR for Alzheimer‘s disease was 1.9(95%CI: 1.2-3.1) 
in diabetic patients 
11. 
Since type 2-diabetes is still under-diagnosed and AD may be 
associated with hyperglycemia, so more attention should be drawn to early diagnosis of 
diabetes
7,8,9,10,11
. 
1.2.2 Macrovascular Complications of Diabetes 
Cardiovascular disease: Diabetes increases the risk of cardiovascular disease (CVD), 
which is the leading cause of mortality in people with either type 1 or type 2-diabetes
4
. 
Diabetes is also strong independent risk factor for developing stroke and cerebrovascular 
disease, increasing risk by 150–400%4. 
1.3 The Global Burden of Disease 
The world became the center of an epidemic of diabetes, which can produce an 
intolerable burden on quality of life worldwide and affect the health care system if 
unchecked will over the succeeding generation
5
. All types of diabetes are rapidly 
increasing particularly type 2 diabetes
5
. According to the findings of the International 
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Diabetes Federation, it is estimated that 382 million people worldwide (or 8.3% of adults) 
have diabetes
5,6
. About 80% of these diabetic patients live in low- and middle-income 
countries
5
. If these trends continue, some 592 million people, or one adult in 10, will have 
diabetes, by 2035
5
. The World Health Organization (WHO) predicts similar results for 
the worldwide increase in diabetes: over 180 million people all over the world have 
diabetes, and the number may become double by 2030
5, 6
.  
The Western Pacific has more diabetic populations with more than 138 million people 
affected
5
 while the North American and the Caribbean region have the second-highest 
relative prevalence of diabetes
5
. An increase in predicted the total number of diabetic 
patients in North America and the Caribbean between 2014 and 2035
6
. An estimated 36.8 
million diabetic people live in the area now, and by 2035, the number is expected to 
increase to 50.4 million
5, 6
. 
1.4 Diabetes in Canada 
The Government of Canada identified that diabetes is a complex health problem and a 
national challenge
12
. According to diabetes statistics in Canada in 2015, the estimated 
prevalence in Canada was 3.4 million patients (9.3%), and it is expected to increase to 5 
million (44%) by 2025
12,13
.  
The most recent statistics in Canada disclosed that diabetic patients are three times more 
likely to be hospitalized with the cardiovascular disease, tweleve times more liable to be 
hospitalized due to renal failure and over 20 times are more likely to be hospitalized for a 
non-traumatic lower limb amputation, compared to the general population 
12, 13
. 
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The Canadian Diabetes Strategy (CDS) was formed in 1999 with an original funding of 
$115 million for five years, for prevention and management of type 2 diabetes and its 
complications. CDS‘s strategy emphases health promotion and chronic disease 
prevention by reducing diabetes risks for Canadians who are at high risk and supports 
early discovery and controlling of chronic diseases
13, 14
. The direct treatment costs for 
people with diabetes in Canada had been estimated $400 million annually for hospital 
care and prescription drugs
9
. Also, there are costs for treating complications and for 
physician care, costs borne by patients, and indirect costs such as premature death, 
disability, and care-giving
14
. 
1.4.1 Diabetes in Newfoundland and Labrador  
Accoroding to the Canadian Diabetes Association (CDA) and National Diabetes 
Surveillance System (NDSS), the Province of Newfoundland and Labrador (NL) has the 
highest prevalence of diabetes (for all ages) in Canada, estimated at 9.3% for 2010 and 
which is expected to increase to 14.4% by 2020
15
. By 2020, it is anticipated that 73,000 
persons in the province will have diabetes, up from 47,000 individuals in 2010
15
. The 
estimated diabetes prevalence by 2015 was 60,200 (11.9%), and is expected to be 84,500 
(16.6%) by 2025
15
. Previous studies in Newfoundland and Labrador showed that males 
and females diagnosed late with diabetes had an increased risk of CVD mortality, other 
associated causes of mortality and hospitalizations compared to those without diabetes
15, 
16
. 
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1.5 Urban/Rural Difference in Diabetes Diagnosis and Outcomes 
Diabetes Mellitus, especially Type 2_diabetes, is considered a major health concern in 
rural communities in low- and middle-income countries
17,18
. Although, there are more 
people with diabetes living in urban (246 million) than in rural (136 million) areas, the 
numbers for the countryside areas are on the increase
5, 6
. 
 
Because rural populations suffer a higher financial and chronic burden from diabetes, 
they constitute an important public health target group as they lack the infrastructure to 
sustain the processes needed to improve healthcare outcomes among persons living with 
diabetes
17,18
. Rural populations often lack adequate access to primary care and specialty 
care services, which are critical for providing quality diabetes care. Rural adults  who are 
less-educated, are more likely to report low incomes, lack health insurance, travel further 
for care and are correspondingly more likely to report deferring care due to cost than 
urban adults
17, 18, 19
. 
1.6 Problem Statement 
Epidemiological studies show an increased rate of type 2-diabetes worldwide. The 
statistics show that every 10 seconds two people develop diabetes and someone dies from 
diabetes-related causes
19, 20
. As the diabetic population continues to increase, providing 
the necessary care for diabetic patients becomes progressively significant to reduce the 
related morbidity and mortality.  
A big challenge with type 2 diabetes is detecting the disease early to prevent 
complications from developing. Previous studies found that about 183 million people, or 
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half of those who have diabetes, are unaware they have the disease
19, 21
. Additionally, 
type 2 diabetes can be present for 9-12 years before being diagnosed, which lead to the 
presence of complications at the time of diagnosis
21
.  
On the other hand, no country can diagnose every person that has diabetes. For example, 
in sub-Saharan Africa, where incomes are often lacking, and governments may not list 
screening for diabetes, the proportion of individuals with diabetes who are undiagnosed is 
as high as 90%
5
. Even in developed countries, nearly one-third of people with diabetes 
are undiagnosed
5
. 
According to Statistics Canada, in 2008/09, Newfoundland and Labrador, Nova Scotia, 
and Ontario had the highest prevalence of diagnosed diabetes
12
. Of the three, the Province 
of Newfoundland and Labrador has the highest prevalence of diabetes (for all ages) in 
Canada
12
. 
In recent years, there has been substantial attention to the geographic characteristics of 
the public health, mainly in the areas of the global health and community 
development.  Previous studies recognized a difference between urban and rural health 
care facilities related to access to care and utilization of healthcare services
22, 23
. These 
studies also showed the difference between urban and rural health care services 
associated with cost and geographic distribution of providers and services
22, 23, 24
. Studies 
that focused on the rural populations noted difficulties in providing care for patients with 
diabetes; however, results are confined to a small area and do not produce globally 
representative evaluations on differences in diabetes care among rural populations
17, 18
. 
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Previous studies revealed mixed findings for urban/rural differences in diabetes diagnosis 
and outcomes. Some studies suggest that people living in rural and remote regions have 
diabetic complications  percentage between 10% and 70% higher than those living in the 
major cities, and proprotion of diabetes-related hospitalization and mortality rise with the 
increasing remoteness of residence
22, 23, 24
. Others show a high prevalence of diabetes 
among urban inhabitants
25, 26, 27
.  
This study focuses on diabetes diagnosis and outcomes (complications and mortality) but 
not from a geographical aspect (rural and urban areas). To our knowledge, this is the first 
study in NL using a GIS approach to identify the variances between rural and urban areas 
and if these differences have an effect on diabetes diagnosis and outcomes. Identifying 
potential individual risk factors and rural/urban factors affecting diabetes in NL could 
help inform intervention strategies to decrease the possibility of diabetes and its 
complications in at-risk populations. Consequently, it can help decision-makers better to 
understand the geographic variations in diabetes diagnosis and management.  
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CHAPTER 2: LITERATURE REVIEW 
To identify relevant articles about rural and urban disparities in diabetes diagnosis, 
complications and mortality, a systematic literature search was performed. This search 
used electronic databases including PUBMED, EMBASE, COCHRANE and CINHAL.  
The initial search comprised the following MESH terms: Diabetes Mellitus, Rural 
Population, Rural Health Services, Rural Health, Urban Health Services, Urban Health, 
Urban Population, Health Disparities, Primary Care, Diabetes Complication, Morbidity, 
Mortality, and Diabetes Outcomes.  
Analyzing the title and abstract of each paper retrieved from the initial literature search to 
identify potentially eligible studies. All articles that did not meet the inclusion criteria 
were excluded. The full text of the remaining papers was obtained for further 
examination. 
The following number of articles, published between 1950 and 2015, from the different 
electronic database were identified: 430 related articles from PubMed; 200 related articles 
from CINHAL, 75 articles from COCHRANE and 90 related articles from EMBASE. All 
of these items were saved to Refworks and placed them in individual folders. When the 
relevant articles were identified, they were put in a newly created folder. Of the 795 
articles, 300 records related to our research question were identified.  
The next step was screening the 300 related articles and focusing on the articles that were 
published over the last five years and related to type 2 Diabetes (DM). Additionally, the 
articles those were readily accessible through MUN‘s library database without the need 
10 
 
of subscription services were only included. Once the screening process was finished, 
250 articles were excluded from the initial 300.  
Consequently, 12 articles published during the past five years related to the objective of 
this study, disparities in rural and urban areas in diabetes diagnosis, complications and 
mortality, were identified. The selected articles follow the eligibility criteria, as shown in 
figure 1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1  The Research Strategy Flow Diagram 
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These articles from different regions and countries showed mixed findings for urban/rural 
differences in diabetes diagnosis and outcomes. Some studies show a high prevalence of 
diabetes and its related complications in the rural areas with less adequate care; others 
show a high prevalence of diabetes among urban inhabitants. All potentially eligible 
studies were considered for review. Table 15 of appendix shows a summary of findings 
relevant to a rural/urban difference in diabetes diagnosis and outcomes. 
Morbidity and quality of life for the old diabetic patients who are living in urban 
and rural areas 
Dos Santos et al. 2013
26
 showed that the prevalence of diabetes in Brazil is higher among 
urban people (3.99%) than in rural populations (2.97%). The elderly urban residents 
stated a greater number of comorbidities and more vision problems and heart problems 
compared to the rural older people. The author found that that the elderly DM patients in 
the rural regions usually presented better socio-demographic situations, a lower frequency 
of morbidity and better quality of life scores than the residents of the urban area. 
Another study by Hye Y. et al. in 2010
25
 identified that the prevalence of T2DM in the 
Korean population was significantly higher in urban (14.5%, P<0.000) than in rural 
(8.6%) residents. However, subjects with a family history of T2DM in the agricultural 
region had a higher risk of T2DM (P<0.000) compared with those in the urban areas. 
These articles showed higher prevalence of diabetes in urban areas than rural areas in 
Brazil and Korea (developing countries). 
 
12 
 
Rural–urban differences in the prevalence of diabetes and heart diseases  
O'Connor et al. in 2012
28
 found that the rural locations had the higher prevalence of 
diabetes and CVD. Those chronic diseases aggravated the well-established lack of 
primary care providers in rural cities. It includes more difficulty obtaining health 
insurance and longer distances to reach health care services. As a result of that medical 
deficiency, populations of rural states in the USA had access to about half of the number 
of general physicians compared to residents of urban locations.   
By performing some statistical analysis, the author examined the basic prevalence of 
diabetes and CVD, which were 8.6% (P < 0.001) and 38.8% (P < 0.001) higher among 
populations living in rural regions versus urban regions, respectively. Thus, persons 
living in rural areas in the USA were more likely to be diagnosed with diabetes than 
persons living in urban areas; they were also more likely to be diagnosed with coronary 
heart disease. 
Another study in the United States by Cheryl et al. in 2011
29
 found that rural veterans 
were more likely to check regularly their feet (74% versus 68%; P<0.004). In contrast, 
urban veterans were more likely to perform blood sugar testing at least once daily (63% 
versus 59%; P< 0.000). On the other hand, the study results showed that rural veterans 
had less access to care, higher exposure to travel obstacles, lower health-related quality of 
life, and a higher prevalence and poorer control of physical health complications. So the 
authors concluded that those residing in rural areas would be limited in their access to 
formal clinical services compared to their urban counterparts. 
13 
 
Quality performance programs have not been designed and implemented with 
consideration of the additional challenges in access, practice characteristics, and 
resources faced by rural physicians. Therefore, rural doctors are less likely to participate 
in performance reporting, and national averages set by urban practice patterns may not 
reflect the diabetes care quality in rural settings.  
These articles from the United States showed higher prevalence of diabetes in rural areas 
than urban areas with providing more qualified care for diabetic patients in urban places. 
Rural-urban disparities in the management and health issues of chronic diseases 
A study in Quebec (Canada) in the early 2000s by Vanasse A et al.
30 
stated that nearly 66% 
of the Quebec inhabitants live in a metropolitan area (CMA), and 12% of them live in a 
small town (CA). Besides, this study found that no rural–urban difference was noticed in 
the incidence emerged across the three chronic diseases (atherosclerosis, osteoporosis, 
and diabetes). But the first observation is that the proportion of MI was greater in small 
towns (CA) and weak metropolitan influenced zones (MIZ) compared with metropolitan 
areas (CMA) while there was no clear trend in the proprotion of diabetes among rural–
urban areas. But, a clinically and statistically significant smaller risk of diabetes was 
observed in moderate MIZ (statistically (P < 0.01) and clinically significant risk (RR ≥ 
1.2 or RR ≤ 0.83) as compared with the risk in a census metropolitan areas. The results 
from this study stated a significantly higher mortality for atherosclerosis and diabetes, in 
non-metropolitan areas with the highest proprotion found in remote regions (weak and no 
MIZ), P < 0.001.  
14 
 
This is a Canadian study on rural-urban disparities in management of the chronic diseases, 
and this study showed high prevalence of diabetes mellitus, atherosclerosis and 
osteoporosis in rural areas. 
Risk elements and co-morbidities of diabetes among adults in rural regions 
A study by Dyck et al. in 2013
31
 showed that unadjusted diabetes prevalence was similar 
among Saskatchewan‘s agricultural regions and was significantly higher among non-farm 
compared to farm inhabitants. Overall, 10.7% of non-farm inhabitants and 6.9% of rural 
residents stated that they received a diagnosis of diabetes from their physicians (p<0.001). 
The study suggested that rural Saskatchewan had higher diabetes prevalence for people 
living in non-farm places with 7.3% compared to 5.1% among those living on farms.  
An American study by Nathan et al. in 2010
19
 showed that a higher percentage of rural 
persons reported diabetes among all racial/ethnic classifications compared to urban 
persons (9.0 vs. 7.7%). On the other hand, rural individuals with diabetes were more 
likely to report not seeing a doctor due to an absence of health insurance, and less liable 
to report participating in Diabetes Self-Management Education (DSME) than urban 
persons. The percentage of rural residents indicates an annual dilated eye examination 
(69.1%) was significantly lower than urban individuals with diabetes (72.4%; P = 0<006). 
So, rural people living with diabetes were more likely to have retinopathy (25.8%) than 
22.0% of urban residents (OR 1.21; P < 0.007).  
There are only two studies in Newfoundland and Labrador by Roche et al. the first study, 
published in 2013
16
 assessed the sex differences in all-cause and cardiovascular mortality 
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and hospitalization for individuals with and without diabetes. Additionally, the study 
evaluated whether or not patients with diabetes were diagnosed early and late
16
. In this 
study, males and females with diabetes were more likely to die and to be hospitalized 
than males and females without diabetes (P< 0.01). During hospitalization, individuals 
with diabetes remained longer than individuals without diabetes for both males (6.4 and 
5.6 days; P< 0.01) and females (7.0 and 5.5 days; P< 0.01). Males with and without 
diabetes had greater risk of all-cause mortality and CVD hospitalizations than females. 
Diagnosis of diabetes on the late stage was positively associated with CVD mortality 
(Hazard ratio (HR) 6.54 [95% CI: 4.80– 8.91]) and CVD hospitalizations (HR: 5.22 [95% 
CI: 4.31–6.33]) among females. Compared to their male counterparts, females were also 
at a significantly higher risk of incurring longer hospital stay (HR: 3.44, [95% CI: 2.47–
4.79] and: HR: 3.33, [95% CI: 2.80–3.95]). 
The second study by Roche et al. in 2014
21
 examined factors associated not only with a 
diabetes diagnosis but also with late diabetes diagnosis for males and females
21
. The 
results of this study showed that men and women with diabetes were older,  more likely 
to live in a rural area and have less education than those without diabetes (P < 0.01). The 
results of this study also displayed that resident in rural areas (HR: 1.47; 95% CI: 1.01-
2.15), getting social care (HR, 2.80; 95% CI: 1.52-5.15), lacking of health awareness (HR: 
2.06; 95% CI: 1.32-3.21) and stress (HR: 1.45; 95% CI: 1.01-2.10) were associated with 
diabetes among females. 
These four articles (three from Canada and one from United States) showed high 
prevalence of diabetes in rural and less accessible areas associated with diagnosis of 
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diabetes in late stages. Late diagnosis of diabetes lead to long hospitlization with high 
mortality proportion. 
Elements of urbanization which are most associated with diabetes 
Attard et al. in December 2012
27
 showed that the prevalence of type 2 diabetes in China 
had become more than doubled from approximately 3% in 1994 to 7–10% in 2008. It was 
the reason for considering China is a home to more than 1.3 billion people and contained 
one-fifth of the world's population. Urbanization might impact diabetes prevalence 
through increased time involved in sedentary lifestyle manners and more ingesting of 
animal products, high-fat foods, and highly handled foods.  
This study examined diabetes prevalence across low, medium and high zones of 
urbanization. The results showed the highest prevalence of diabetes is in highly urbanized 
areas. Besides, diabetes prevalence differed by sex (p<0.001, χ2 test); with a higher mean 
prevalence through all levels of urbanization in men (8.7% [SE 0.5]) vs. women (6.7% 
[0.4]). High vs. low urbanization was related to and near twofold higher diabetes 
prevalence (men OR: 2.02, 95% CI: 1.47- 2.78; women OR: 1.94, 95% CI: 1.35- 2.79) 
after adjusting for individual-level factors and accounting for a gathering at the 
community and province levels
27
.  
―When populations grow, the population of a place may turn from a city into nearby areas, 
this is called urbanization‖27. This study form China showed that the urbanization plays a 
big role in increasing the prevalence of diabetes in China by increasing the time of 
sedentary life. 
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Rehospitalization proportions among rural Medicare beneficiaries with diabetes  
A study by Kevin et al. in 2012
32
 found that around 20% of Medicare beneficiaries with 
diabetes in Columbia discharged from a hospitalization had a subsequent readmission 
within 30 days, with only 10% of intended readmissions. The authors discovered that 
12.9% of rural patients went for follow-up physician visit within 30 days compared to 
14.9% of urban. Having a doctor visit within 30 days of discharge was a positive 
predictor of having a readmission (OR: 2.24, 95% CI: 1.95-2.57). Consequently, 
residents of remote rural counties were less likely to have a readmission (OR: 0.74, 95% 
CI: 0.57-0.95)
32
.  
The article showed that people in rural areas have less adequate care including a 
physician visit which affected the hospitalization risk in case of advanced cases with 
diabetic complications
32
. The authors suggested characteristics and relative factors that 
were influencing rural residents and placed them in risk for improper care. These factors 
included geographic distance, lack of transportation, higher poverty levels, insufficient or 
disjointed health care infrastructure, and a lack of other resources
32
.  
Spatial analysis and correlates of county-level diabetes 
The medical geography is an important "new" area of health research that is a fusion 
between geography and medicine by dealing with the geographic features of health and 
healthcare. The aim of this new field of health research is improving the empathetic of 
the various influences which affect the health of inhabitants and the individuals. It is also 
called health geographic. 
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A study by Hipp JA et al. in 2015
33
 found a significant spatial clustering of county-level 
diabetes prevalence in the United States (p <0.001). The proportion of the population that 
were living below the federal poverty level and percentage non-white people were related 
to diabetes in some regions. The authors mentioned that poverty line, physical inactivity, 
and walking or cycling to work were each significantly related to county-level diabetes 
prevalence
33
. 
Another study by Chris G. et al.
34
 found that there was a clustering of DM prevalence in 
the central core of the City of Winnipeg. This cluster associated with a larger Aboriginal 
population, low education, family low income, single parent families, high 
unemployment, poor housing stock, high crime rates and high levels of smoking. 
Significant Moran‘s I values (P<0.001) confirmed this visual impression for all values34.  
Geographical methodologies offer chances to associate individuals with characteristics of 
their local setting and to assess spatial modeling of health outcomes
34
. Geographic 
information systems can help to connect aspects of where we are living with our health 
consequences and skills and have been working in several advanced studies of diabetes 
diagnosis and outcomes
34, 35
. 
On the other hand, we could not find any articles in Newfoundland and Labrador that are 
related to disparities in diabetes diagnosis and outcomes from a geographical view. This 
study will assess the differences in diabetes diagnosis, mortality and complications 
among rural and urban areas by performing the statistical and geospatial analysis. 
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CHAPTER 3: METHODOLOGY 
Ethics: The study protocol was approved for ethics by Newfoundland and Labrador 
Health Research Ethics Board (HREB) - reference number (15.140) 
3.1) Research Question and Objective 
 
3.1.1) Research Question  
1) In adults age 20 and older in NL, does place of residence (rural vs. urban) affect 
the likelihood that a patient newly diagnosed with diabetes will have 
complications and comorbidities
*
 at the time of diabetes diagnosis? 
* A patient newly diagnosed with diabetes who has diabetic complications or comorbidities will be referred to as a 
complex case. 
2) In adults age 20 and older in NL, does place of residence (rural vs. urban) affect 
the likelihood of developing complications and/or comorbidities and death after 
the diagnosis of diabetes? 
3.1.2) Research Objective 
1) Assess disparities in rural and urban areas and their effect on the development 
of a complex case (patients with complications and comorbidities at the time 
of diabetes diagnosis) in adults age 20 years and older in NL. 
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2) Assess presence of disparities in rural and urban area and their effect on 
outcomes related to diabetes (morality, morbidity) five years after getting 
diagnosed with diabetes mellitus in adults age 20 years and older in NL. 
 
3.2)  Hypotheses 
1a)  Ho:   Getting diagnosed as a complex case for adults aged 20 years and older 
in Newfoundland and Labrador is not associated with place of residence 
(rural/urban). 
 
2a)  Ha: Getting diagnosed as a complex case for adults aged 20 years and older 
in Newfoundland and Labrador is associated with living in rural area. 
 
1b) Ho: Diabetes outcomes (complications, mortality) in urban areas is not 
different from the outcomes in rural area among adults aged 20 years and older 
five years after getting diagnosed with diabetes mellitus in Newfoundland and 
Labrador. 
 
2b) Ha: Diabetes outcomes (complications, mortality) in urban areas are different 
from the outcomes in rural area among adults aged 20 years and older five years 
after getting diagnosed with diabetes mellitus in Newfoundland and Labrador. 
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3.3)  Study Population 
All adults 20 years and older from NL who were in the Canadian Chronic Disease 
Surveillance System and who developed diabetes between 1998 and 2003 were included 
in the cohort. Pregnant women with diabetes were excluded from the study. At the time 
of entry into the cohort, the presence of diabetic complications or and co-morbidities 
were assessed. The individuals in the cohort were then followed from the date of 
diagnosis for five years or until their death. Diabetic complications and comorbidities 
were assessed during the follow-up period. 
 3.4)  Data Sources  
This retrospective cohort study utilized administrative data in Newfoundland and 
Labrador, Canada. Databases included were: (1)The Canadian Chronic Disease 
Surveillance System (CCDSS), 1998-2008; (2) the Clinical Database Management 
System (CDMS), 1998-2008 and (3) the Medical Care Plan (MCP) Fee-For-Service 
Physician Claims Database, 1998-2008. 
The CCDSS is a co-operative network of provincial and regional surveillance systems 
and uses an authorized case definition to detect persons with diabetes (ICD-9 Code 250).  
The MCP system contains information related to services provided by fee-for-service 
physicians under the provincial Medical Care Plan (MCP).  
The CDMS is the provincial hospital departure records that release demographic, clinical 
and interventional data for patients admitted to all acute health care services and surgical 
day care in NL. 
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The resulting database is linked by NLCHI (a trusted third party for health data in this 
province) with demographic and social data generated from the Census and Statistics 
Canada annual mortality data files. 
 3.5)  Data Preparation 
The data collected by NLCHI went through data cleaning using STATA 13 before it was 
ready for ArcGIS incorporation. Among some of the more important changes applied to 
the database was reshaping (from long to wide) which used de-identified patient numbers 
and fiscal year as both of the primaries. Variables were also created for further 
exploration of the dataset, such as complex diagnosis which was defined using the 
number of health complications. A patient with one or more complications at the time of 
diabetes diagnosis was considered to be a complex patient. Those complications included 
stroke, CVDs, renal failure and amputation. Other variables included the age at the time 
of diagnosis, the number of visits to a specialist or general physician, and the number of 
hospital separations.   
Once the data was cleaned, it was transferred to a file type that can be used by ArcGIS. 
Once in ArcGIS, relational joins were made between postal code points, the file which 
contains all of the spatial data attributed to each unique postal code. 
 3.6)  Study Design - Strategy and Frameworks 
This study was a cohort study. In this cohort study all subjects had the same potential 
length of follow-up without any losses. Additionally, this was a population-based, 
retrospective cohort study of adults 20 years and older diagnosed with diabetes, using 
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health administrative databases from 1998 to 2008 in Newfoundland and Labrador (NL), 
Canada. The individuals in the cohort were followed from the date of diagnosis until 
either their death or the end of the study (2008).  
The individuals included in the cohort were those people diagnosed with diabetes 
between 1998 and 2003, and then five years of follow-up for each patient were identified 
starting from the date of his/her diagnosis. For example, if the year of the diagnosis was 
1998, he/she was followed until 2003 for a total of five years. If a patient had been 
diagnosed with diabetes in 2003, he/she was followed up until 2008 for a total of five 
years. Through those five years of follow-up, we recorded the following events: the 
number of the complications and/or comorbidities which this patient had, the number of 
visits to family doctors and specialists, the number of hospitalizations through the five 
years period of study, and the year of death if it happened during the study period. 
3.7)  Research Variables 
 
3.7.1)  Diabetes Mellitus  
The Canadian Chronic Disease Surveillance System (CCDSS) is a cooperative system of 
provincial and regional surveillance systems and uses a nationally authorized case 
definition to detect persons with diabetes (ICD-9 Code 250).  According to CCDSS, a 
diabetic case definition is required one hospitalization or two or more physician claims 
with a diagnosis of diabetes during a 2-year period
36
. Cases remain in the CCDSS until 
receiving a record of their death or leaving the province. This case definition has a 
sensitivity of 86% and a specificity of 98% for detecting population who had diabetes. To 
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find the incident cases of diabetes, a clearance period of 3 years was applied to the above-
mentioned definition
37
. The CCDSS diabetes case definition excludes women with 
gestational diabetes. 
3.7.2)  Dependant Variables:  
3.7.2.1) Complications and/or Comorbidities at the Time of Diagnosis (Categorical 
Variable) 
Diabetes in this study was classified as a complex case depending on the presence of 
comorbidities and diabetes-related complications at the time of diagnosis. Individuals 
diagnosed early did not have any comorbidities/diabetes-related complications at the time 
of their case dates. Patients without any comorbidity or diabetes-related complications 
within one year before or after the diabetes case date were classified as not having any 
complications at the time of diagnosis, whereas those with any comorbidity or diabetes-
related complications at the time of diagnosis were defined as complex cases.  
To identify complex cases of diabetes, patients‘ records were linked to the Medical Care 
Plan and Clinical Database Management System data. Using this linkage, any records of 
comorbidities and/or diabetes-related complications were identified and compared with 
the diabetes case dates.  
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3.7.2.2)  Diabetes Outcomes 
3.7.2.2.1) Complications and/ or Comorbidities During the Study Period 
3.7.2.2.1.1) Type of Diabetic Complications and Comorbidities (Categorical 
Variable) 
Like any other chronic disease that primarily affects middle-aged and older individuals, 
type 2 diabetes is usually complicated by other medical conditions. The diabetes related 
conditions that were used to define diabetes complications in this study are listed in Table 
1. Diabetes complications and/ or comorbidities in this study were defined as any records 
of diabetes-related comorbidities/complications occurred during the study period. All 
patients diagnosed with diabetes were followed until the end of the study and any records 
of comorbidities and/or complications during the study period were identified. 
 
Table 1: Diabetes Related Conditions Used to Define Diabetes Complications in This Study
16 
CONDITIONS ICD-9-CODES ICD-10-CA CODES 
 
Cardiovascular Disease 390-448 100-178 
Ischemic Heart Disease 410-414 120-125 
Acute Myocardial 
Infarction 
410 121-122 
Heart Failure 428 150 
Acute Renal Failure 584  
Renal Disease 585-586 N18-N19 
Lower Limb Amputation 96.11-96.12 1VC93LA 
Retinopathy 362 H35 
Atherosclerosis 440  
Amyloidosis 277.3 E85 
 All patients regardless of whether they were a complex or non-complex case were 
followed until the end of the study for any additional records of comorbidities and/or 
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diabetes-related complications that may have occurred after getting diagnosis with 
diabetes (Cardiovascular disease, Renal disease, Diabetic foot or Stroke). 
3.7.2.2.1.2) Number of Complications  
The numbers of complications and/or comorbidities during the study period were 
classified into: 0 = no complications at all, 1 = only one complication present, 2 = two 
complications present and 3 = 3 or more complications present. 
3.7.2.2.2)  Mortality (Categorical Variable) 
Mortality was defined as a record of death that occurred during the study period. 
Mortality was defined as a categorical variable; patients were classified as alive or dead 
during the study period. All patients diagnosed with diabetes were followed until the end 
of the study and records of death were identified in our database during the study period.  
3.7.3) Covariates/ Control Variables: 
3.7.3.1) Demographic Variables  
Sex (Categorical Variable) and Age (Categorical Variable) 
This study focused on male and female patient age 20 years and older who had been 
identified in the CCDSS as having been diagnosed with diabetes between 1998 and 2003. 
The patients were categorized into the following four age groups at the year of diagnosis, 
according to Canadian Diabetes Association (CDA) screening guidelines, at the time of 
diagnosis with diabetes: 20 – 39 years; 40 – 49 years; 50 – 59 years; 60 – 69 years and 70 
years or more. 
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3.7.3.2) Utilization of Healthcare Services 
Records of MCP Fee-For- Service Physician Claims and hospital discharges were used to 
identify the number of hospital, physician and specialist visits during the study period. 
Healthcare utilization in this study were considered as categorical variables in the 
database and included outpatient services (visits with general practitioners and specialists) 
and inpatient services (hospitalization and length of stay). 
Using an approach suggested by Donald E. Fetterolf based on statistical outliers and 
healthcare providers opinions on the number of regular visits with healthcare system
38; 
the number of the visits was classified as follows: 
a) Physician Visits were defined as the number of physician visits (General 
Practitioner and Specialists) per year among people during the five-year 
follow-up. Then by taking the mean of physician visits during five-year 
follow-up, these visits were categorized into the following groups: 
Service Accessibility Visits per year 
Non User 
No Visits 
Access to Physician 
One Visit 
Regular Visit 
2 – 6 Visits 
High User 
7 -12 Visits 
Extreme User 
≥ 13 Visits 
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b) Hospitalization was defined as the number of hospitalizations per year during 
the five-year follow-up. Hospitalization was categorized as:  
Yes: there was one or more hospitalization 
No: the patient had never been hospitalized  
c) Length of stay at hospital was defined as the number of days spent in the 
hospital per year during the five-year follow-up. This variable was considered 
as a continuous variable. 
3.7.3.3) Rural/ Urban Areas  
To be able to reflect the geographical realities of Newfoundland and Labrador, we 
assessed different classifications for rural/urban areas using alternative spatial models.   
Using the six digits postal code (categorical variable), we georeferenced the study 
population for identification of rural/urban differences and compare groups. Additionally 
for detect rural/ urban access to health care facility, six digit postal code was used to 
identify rural/urban distance from healthcare services. 
Several alternative definitions of ―rural‖ are available for national level policy analysis in 
Canada. Different definitions generated a different number of ―rural‖ people. Even if the 
number of ―rural‖ people was the same, different people were classified as ―rural‖ within 
each definition.  
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a) Census Rural Area is defined as residents who are living outside the spaces of 
1,000 people or more, or residents living outside places with densities of 400 or 
more people per square kilometer
39
. 
b) Rural and small town(s) is (are) defined as the population living in cities and 
metropolises outside of the commuting zone centers with 10,000 people or 
more
39
. 
c) Rural communities are defined as the population in communities with densities 
less than 150 people per square kilometer
39
. 
d) Non-Metropolitan Regions are defined as a population existing outside of areas 
with major urban settlements of 50,000 or more people. Non-metropolitan areas 
contain urban settlements with less than 50,000 people and areas with no urban 
settlements (―urban settlements‖ are known as places with 2,500 or more of 
populations)
 39
. 
e) Rural Postal Codes are defined as areas serviced by rural way transfer from a 
post office. ―0‖ in the second location of a postal code means a ―rural‖ postal code 
(also referred to as ―rural‖ forward sortation area (―rural‖ FSA)). This method of 
defining an area as "rural" is no longer valid in New Brunswick and some parts of 
Quebec
39
. 
f) Agricultural Land Proportion is another definition for rural/urban areas. Urban 
areas have a low proportion of agricultural land compared to rural areas
39
. 
g) The Accessibility-Remoteness (A-R) index: the accessibility is an important 
factor in providing facilities to the overall community. Based on this, the 
Newfoundland and Labrador Statistics Agency (NLSA) established the A–R 
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index to classify societies within the province according to the ease of access to 
government and community services
40
. Communities with the highest 
accessibility are the regions with government service centers and a health care 
center.  On the other hand, very remote communities are isolated and must utilize 
transports to get to regional and provincial service centers.  According to NLSA, 
only a small percentage (2.6%) of the total population is located in remote and 
very remote areas. Moreover, according to this index, 83.9% live in accessible 
and highly accessible localities
40
. 
According to the A-R index, each community was assigned a continuous numeric value 
that ranged from 0 to 1. The A-R index value was then partitioned into six classifications, 
ranging from ‗Highly Accessibility‘ to ‗Very Remote‘, as shown in Table 2. 
 
Table 2:  Accessibility-Remoteness Classifications
40 
Classification Access to Goods and 
Services 
Percentage of total 2011 
Population 
Highly Accessible Unrestricted 68.3% 
Accessible Some Restriction 15.6% 
Somewhat Accessible Considerable Restriction 8.6% 
Moderately Remote Significant Restriction 4.9% 
Remote Very Restricted 1.5% 
Very Remote Little / No Access 1.2% 
From a geographical perspective, classification of accessibility is defined as the road 
distance between an origin community and a set of services. As this road distance plays a 
great role on the chances of contact between people and these services, accessibility is a 
necessary variable in establishing new rural-urban classification. The highest accessible 
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zones can be considered as urban centers while the lower accessible communities are an 
example of rural zones
40
.  
In the individual level analysis, the continues measure for the A-R index values were 
used while in the community level analysis a fuzzy set model was used for visualization 
analysis. Using a fuzzy set, we were able to have varying degrees of membership applied 
to the remoteness index that varied from highly accessible to extremely remote. We 
found that somewhat accessible (remote index value = 0.329) was a good cut-off point 
for remoteness, so we divided each remoteness score by that number; we made sure that 
anything above remote index value did not exceed one. This meant that communities that 
were closer to being accessible (i.e. 0.328) were not classified as being remote since it is 
more likely that travel time to services for a given community with a score closer to the 
cut-off are more similar to somewhat accessible communities than to extremely remote 
areas. After creating a histogram of the fuzzy set, we found that the 50
th
 percentile 
reflected the urban or more accessible population while anything above reflected the rural 
or more remote population. We used this information to create our two subsets of data to 
be able to compare rural and urban populations at the community level analysis. This 
comparison is an important one since urban and rural populations were found to behave 
differently in other studies. Our first subset would include highly accessible to somewhat 
accessible communities (fuzzy remoteness < 0.5), while the other would include 
somewhat accessible to extremely remote communities (fuzzy remoteness > 0.5).  
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A GIS approach to define urban/rural area 
Using GIS we combined a transformed different maps into a set of polygons (such as a 
community or a census subdivision), lines (such as streets, highways or rivers), and 
points (such as a healthcare facility). The diabetes data were also georeferenced using 
postal codes and linked to the correct polygons, line, or point. To identify the urban/rural 
area reflecting the realities of the geographies in Newfoundland and Labrador, we entered 
the aforementioned classification as different layers in GIS. NL Stats Agency Local 
Areas (Sometimes referred to as Neighborhoods) were used for the analysis. 
  3.8)  Data Analysis 
Different levels of analysis were performed. Individual level analysis, including bivariate 
and multivariate analyses, was used to show rural/urban differences in diabetes diagnosis, 
complications and demographic characteristics by using STATA software. 
The logistic regression was employed to model the relationship between a dependent 
variable (complex case, mortality and complications) and an independent variable 
(rural/urban) adjusting for other crucial covariates (sex, age and health care utilization). 
The created model, based on the logistic regression, enabled us to look at the significance 
of the relationships (between dependent and independent variable) and allowed us to 
examining the effect of several (possibly related) variables simultaneously. 
The odds ratio (OR) produced by logistic regression, ―represents the odds that an 
outcome happened given a particular exposure, compared to the odds of the outcome 
happening in the absence of that exposure‖. The OR is a measure of the association 
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between exposure and an outcome (living in the rural/urban areas and the diabetic 
complications and mortality) with adjusting other crucial variables (sex, the age of the 
patients and healthcare utilization). When a logistic regression is calculated, the 
exponential function of the regression coefficient (eb1) is the odds ratio associated with a 
one-unit increase in the exposure. 
Furthermore, calculating the p-value determined if there is any significant relationship 
between the dependent and independent variables. By rejecting the null hypothesis (H0: 
exposure and outcome are independent) where p-value was less than 0.05, it was 
straightforward to detect the significant relationships and vice versa.  
A variety of community and environmental factors are involved in the development of 
chronic disease, which goes beyond the concept of personal choice. For that reason, 
understanding diabetes diagnosis and outcomes (mortality, complications and 
comorbidities) from an ecological perspective provides opportunities to focus on the 
environmental and social impacts and develops a more precise model of how population 
health factors might interact with the individual characteristics to produce variations in 
diabetes diagnosis and outcomes
. 
 
Consequently, we conducted another two levels of geospatial analysis: visualization and 
community level analysis. The individuals were geo-referenced using the six-digit postal 
code and assigned to neighborhood and community.  ArcMap-GIS 10.2 software package 
was used to produce choropleth maps, perform descriptive and geospatial analysis for 
diabetes diagnosis and outcomes in Newfoundland and Labrador. NL Stats Agency Local 
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Areas (Sometimes referred to as Neighborhoods) were used for the analysis. The shape 
files mappigs for the polygons came from the federal, provincial governments as well as 
the NL stats agency through Memorial University: a. NL Base map: provincial, b. 
Remoteness index: provincial, c. Hospital locations and roads: provincial, d. Local Areas: 
NL Stats Agency, e. Postal codes: federal, f. Every other level of geography (ie. CSD, 
DA, etc.): federal. The results of this study identified the location of the highest 
proportion of complications at the time of diagnosis, and if there was any association 
between place of residence and presence of diabetes outcomes. Kappa statistics were used 
to show the level of agreement between the different definition of rurality across 
Newfoundland and Labrador. 
 
The data for this province formed a sufficiently large sample size to allow for community 
level geospatial analysis. The geospatial analysis involves the collection, integration, 
manipulation and presentation of digital maps, GPS, satellite imagery and geocoded data. 
The outcomes of this type of geographic analysis are described regarding absolute or 
relative locations, street order or postal code. 
The first stage of spatial data analysis included mapping the distribution of diabetes 
diagnosis and outcomes by the community. Phase two included the use of two spatial 
statistics to determine spatial clustering (global Moran‘s I and local Moran‘s I). Global 
Moran‘s I statistic is a global measure of spatial autocorrelation, a geographical 
phenomenon that can test whether community diabetes diagnosis and outcomes values 
are randomly distributed or whether neighboring values tend to be more similar than non-
neighbouring
42
. Moran‘s I shows the power of spatial autocorrelation on a scale 
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extending from +1 to -1. A rate of +1 specifies positive spatial autocorrelation where high 
values are close to other high values. On the other hand, a value of -1 signifies negative 
spatial autocorrelation where high values tend to be near low values. A value of zero 
specifies no spatial autocorrelation, or that the data are randomly distributed within the 
geographical boundary of the study area
 43, 44
. 
The local Moran I statistic detects whether or where local clustering occurs; this cannot 
be provided by the global Moran‘s I statistic42. The local Moran‘s I identify individual 
clusters or small regions of clusters that may not be obvious within the global pattern
42,43
. 
A cluster and outlier analysis tool in a geographic information system (GIS) was used to 
analyze the local Moran‘s I statistic and associated Z-score. This tool examines whether 
the homogeneity (or heterogeneity) in values between a community and its neighboring 
communities are greater than what would be expected by chance
44,45,46
.  Community with 
a high Moran‘s I statistic indicates that its values are close in magnitude to the nearby 
community‘s diabetes diagnosis and outcomes values47, 48,49. A small Moran‘s I statistic 
shows an ‗outlier‘ where the diabetic diagnosis and outcomes of a community are 
dissimilar to the neighboring values
49, 50,51
. 
The ordinary least square (OLS) multivariate regression model was performed to show 
the linear association between diabetes diagnosis and outcomes and rural/remoteness 
areas in the province
51,52. The goal of this ―global model‖ is to verify the positive 
relationship found in previous part of the studies. In this study, the first OLS model used 
percent of complex cases in the community as the dependent variable and average 
remoteness index score, cumulative incidence at the community level, the average age at 
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the time of diagnosis and percentage of regular family medicine utilization as 
independent variables. 
 The second OLS model used the percent of mortality in the community as the dependent 
variable and average remoteness index score, percentage of complications and 
comorbidities at the time of diagnosis at the community level, the mean age at diagnosis 
and percentage of hospitalization at the community level as independent variables. 
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CHAPTER 4: DESCRIPTIVE RESULTS 
This retrospective cohort study used administrative data from Newfoundland and 
Labrador, Canada. The study population from 1998 to 2003 included 20,292 patients.  
The sample size was reduced through the exclusion of 104 patients due to blank postal 
code entries and 2,392 invalid postal code entries → the total study population after 
excluding patients based on postal code errors was 17,796 persons. 
4.1) Characteristic of Study Population 
Of the 17,796 subjects investigated, 50.1% of patients (n= 8,923 subjects) were men and 
49.9% of patients (n= 8,873 subjects) were women. As shown in Table 4, the percentage 
of diabetes mellitus was higher in the elderly. From 17,796 patients, 15.3% of patients 
(n= 2,720 subjects) were diagnosed as complex cases, which refer to the presence of 
complications and comorbidities at the time of diagnosis. For diabetes outcomes during 
the five-year follow-up period, the  proprtion of mortality was 17.2% of patients (n= 
3,053 subjects), while 84.7% of patients (n=15,076 subjects) did not develop any 
complications and/or comorbidities; 8.8% of patients (n= 1,558 subjects) developed one 
diabetic complication; 4.7% of patients (n= 844 subjects) developed two types of 
complications and 1.8% of patients (n= 318 subjects) developed three or more types of 
complications by the end of study period. 
4.2) Utilization of Health Care Services 
MCP Fee-For- Service Physician Claims and hospital claims were used to identify the 
number of hospitalizations, general practitioner (GP) and specialist visits during five- 
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year follow-up. The GP visits were categorized into five groups: 6.7 % of patients (n= 
1,188 subjects) that did not have any previous GP visits, 1.2 % of patients (n= 211 
subjects) that had only one visit, 41.3 % of patients (n= 7,342 subjects) that had two to 
six visits, 34.6 % of patients (n= 6,165 subjects) that had seven to twelve visits and 16.2 % 
of patients (n= 2,890 subjects) that had thirteen or more visits. Specialist visits were also 
categorized into five groups: 3.2 % of patients (n= 561 subjects) that did not visit a 
specialist, 3.3 % of patients (n= 589 subjects) that had one visit, 66.9 % of patients (n= 
11,918 subjects) that had two to six visits, 19.8 % of patients (n= 3,522 subjects) that had 
seven to twelve visits and 6.8 % patients (n= 1,206 subjects) that had thirteen or more 
visits.  
The hospitalization was defined as the act of placing a person in a hospital as a patient. 
The number of the hospitalization during a five-year follow-up period was categorized 
into four groups: 41.2 % of patients (n= 7,330 subjects) that were not hospitalized, 3.4 % 
of patients (n= 602 subjects) that were hospitalized for one time, 55.4 % of patients (n= 
9,858 subjects) that were hospitalized between two and six times and .03 % of patients 
(n= 6 subjects) that were hospitalized seven or more times. The last healthcare service 
considered in our analysis was the length of stay at a hospital, which was categorized into 
six groups: 41.5 % of patients (n= 7,384 subjects) that did not stay at the hospital, 2.6 % 
of patients (n= 465 subjects) that spent one day in a hospital, 38 % of patients (n= 6,760 
subjects) that spent between two and six days, 11.5 % of patients (n= 2,051 subjects) that 
spent between seven and fourteen days, 4.6 % of patients (n= 813 subjects) that spent 
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between fifteen and thirty days and 1.8 % of patients (n= 323 subjects) that spent more 
than thirty days in a hospital. 
  Table 3: Characteristics of Study Population During the Study Period (n=17796) 
 Percentage (Total Number) 
Sex  
 Men 50.1 (8,923) 
Age Group  
 20 - 39 8.6 (1,537) 
40 -49 15.3 (2,719) 
50 -59 24.5 (4,362) 
60 - 69 23.4 (4,170) 
≥ 70 28.1 (5,008) 
Visit with Family Physicians  
 -No visit (Nonuser) 6.7 (1,188) 
-One Visit  1.2 (211) 
-2–6 Visits (Regular user) 41.3 (7,342) 
-7–12 (High User) 34.6 (6,165) 
 
 
16.2 (2,890) 
-≥13 (Extreme User) 
Visit with Specialists  
 -No visit (Nonuser) 3.2 (561) 
-One Visit  3.3 (589) 
-2–6 Visits (Regular user) 66.9 (11,918) 
-7–12 (High User) 19.8 (3,522) 
-≥13 (Extreme User) 
 
6.8 (1,206) 
Hospitalization  
 NO 41.2 (7,330) 
 YES 
1 Time 3.4 (602) 
2-6 Times 55.4 (9,858) 
≥7 Times 
 .03 (6) 
 
Hospital Length Stay  
 
0 41.5 (7,384) 
1 Day 2.6 (465) 
2-6 Days 38 (6,760) 
7-14 Days 11.5 (2,051) 
15-30 Days 4.6 (813) 
>30 Days 1.8 (323) 
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Complications and comorbidity at time of 
diagnosis 
15.28% (2,720) 
Mortality 17.16% (3,053) 
Complications and Comorbidities during 5 years 
follow up 
 
 
No Complication 84.7 (15,076) 
One Complication 8.8 (1,558) 
Two Complications 4.7 (844) 
≥3Complications 1.8 (318) 
Table 4 shows an increase of health care service utilization for the one year period after 
diabetes diagnosis compared to the one year period before the diagnosis. The mean of GP 
visits increased from 1.96 visits (95% CI: 1.94-1.98) one year before diagnosis to 2.18 
visits (95% CI: 2.16-2.19) one year after diagnosis. That lead to an increase in the mean 
number of GP visits during a five-year period to 2.53 visits (95% CI: 2.51-2.54). The 
average of specialist (SP) visits increased from 1.38 visits (95% CI: 1.36-1.41) one year 
before diagnosis to 1.59 visits (95% CI: 1.57-1.61) one year after diagnosis that lead to an 
increase in the mean number of SP visits during a five-year period to 2.24 visits (95% CI: 
2.23-2.25). Additionally, table 6 shows a slight increase in the mean number of the 
hospitalizations from 0.15 time one year before diagnosis (95% CI: 0.15-0.16) to 0.24 
time one year after diagnosis (95% CI: 0.23-0.25) that led to an increase in the mean 
number of hospitalization during a five-year period to 1.14 times (95% CI: 1.13-1.16). 
There was also an increase in the mean of the length of stay from 0.31 days one year 
before diagnosis (95% CI: 0.30-0.33) to 0.51 days one year after diagnosis (95% CI: 
0.51-0.53) that led to an increase in the mean number of length of stay in hospital during 
a five-year period to 1.405 days (95% CI: 1.31-1.42).   
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Table 4:  Mean and 95% Confidence Interval of Healthcare Utilization of Patient Diagnosed With 
Diabetes One Year Before and After Diagnosis and During the 5 Year Study Period 
Health Care 
Utilization 
1-Year Period 
Before Diagnosis 
1-Year Period 
After Diagnosis 
 
During 5 Year 
Period / Per year 
 
GP* Visits 1.96 ( 1.94-1.98) 2.18 (2.16-2.19) 2.53 (2.51-2.54) 
SP* Visits 1.39 (1.37-1.40) 1.59 (1.58-1.61) 2.24 (2.23-2.25) 
Hospitalizations 0.15 (0.15-0.16) 0.24 (0.23-0.25) 1.14 (1.13-1.16) 
Hospital Lengthy 
of Stay (Days) 
0.31 (0.30-0.33) 0.52 (0.50-0.54) 1.41 (1.39-1.42) 
*GP: Visits with general practitioner 
*SP: Visits with specialist 
 
4.3) Place of Residence 
The study population was georeferenced using six digits postal codes. To be able to 
reflect the realities of the geographies in Newfoundland and Labrador we assessed 
different classifications for rural/urban areas using alternative geographical classification. 
As mentioned before, there are different definitions for rural and urban areas. Table 5 
shows the difference between each of the definitions regarding the percentage of the 
people living in both rural and urban areas for each classification scheme. 
The definition of rurality according to the Newfoundland and Labrador Statistics 
Agency‘s Remoteness Index (A-R Index), classified 51.5% of NL‘s population as living 
in rural areas and 48.5% as residing in urban areas. The postal code classification for 
rurality (A0) classified 62.5% of NL‘s population as living in rural zones and 37.5% as 
living in urban areas. The Census Rural Area classified 39.5% of residents as living in 
rural regions and 60.5% as living in urban areas. The Census Metropolitan Area ranked 
63.6% of residents as living in rural areas and 36.4% as living in urban zones. The 
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Community Zone classified 63.5% of residents as living in rural regions and 36.5% as 
living in urban areas. The Remoteness Index, Rural Postal Codes and Census Rural Areas 
all provided similar results concerning rural/urban classification and the attributed 
populations when compared to Census Metropolitan Area and The Community Zone 
classification scheme. 
Table 5: Rural/ Urban Classification by Type of Geographic Classifications (N=17796) 
Geography Classification 
Type 
 
RURAL % URBAN % 
Remoteness Index 51.47 48.53 
Rural Postal Code 62.47 37.53 
Census Metropolitan Area 63.56 36.44 
Census Rural Area (<1000 
people in place= Rural) 
39.46 60.54 
Community Zone (60 Km) 63.46 36.54 
Table 6 shows the measurement of an agreement between different rural and urban 
definitions. There was a good agreement between the A-R Index and Postal Code (Kappa: 
0.76, P-value< 0.001, Percent Agreement: 85.88%), fair agreement between the A-R 
Index and the Census Rural Area (Kappa: 0.57, P-value <0.000, Percent Agreement : 
78.47 %), fair agreement between the Postal Code and the Census Rural Area (Kappa: 
0.48, P-value< 0.000, Percent Agreement: 72.85%) and a very good agreement between 
the Community Zone and the Census Metropolitan Area (Kappa: 0.78, P-value< 0.000, 
Percent Agreement : 89.7 %). As shown in table 6, there was no agreement between the 
following definitions of the rurality: the Census Metropolitan area and remoteness index 
(Kappa: -0.67, P-value < 0.000, Percent Agreement : 15.87%), the Census Metropolitan 
Area and the Postal Code (Kappa: -0.69, P-value < 0.000, Percent Agreement: 9.56%), 
the Census Rural Area and the Census Metropolitan Area (Kappa: -0.54, P-value < 0.000, 
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Percent Agreement: 27.5%), the Community Zone and the Remoteness Index (Kappa: -
0.59, P-value: < 0.000, Percent Agreement : 19.8%), the Community Zone and the Postal 
Code (Kappa: -0.63, P-value < 0.000, Percent Agreement : 12.8%) and the Community 
Zone and the Census Rural (Kappa: -0.48, P-value < 0.000, Percent Agreement : 30.3%). 
Based on the Kappa measurement, the postal code, and the A-R index definitions were 
chosen for categorizing rural and urban areas in further analysis. 
Table 6: Measuring Agreement between Different Rural/Urban Definitions 
 Remoteness 
Index  
(A-R index) 
Rural 
Postal 
Code 
Census 
Metropolitan 
Census 
Rural 
Community 
Zone 
Remoteness 
Index 
     
Rural Postal 
Code 
0.76* 
    
Census 
Metropolitan 
-0.67
NS
 -0.69
NS
 
   
Census 
Rural 
0.57* 0.48
*
 -0.53
NS
 
  
Community 
Zone 
-0.59
NS
 -0.63
NS
 0.78
*
 -0.48
NS
 
 
*P-value <0.0001 for Kappa agreement 
4.3.1) Characteristics of Study Population According to the Place of Residence 
As shown in Table 7, there were 9,368 (4,589 men, 4,779 women) rural diabetic patients 
and 8,428 (4,334 men, 4,094 women) urban diabetic patients included in our study 
population. There were significantly older diabetic living in rural regions compared to 
those living in urban regions (60 – 69 years: 23.6% of rural patients compared to 23.2% 
of urban patients and ≥70 years: 30% of rural patients compared to 25.9% of urban 
patients, P<0.0001). Young urban patients (20 – 49 years) had a higher prevalence of 
44 
 
diabetes compared to young rural patients (20 -39 years: 9.4% urban patients compared to 
7.9 % rural patients and 40 – 49 years: 16 of urban patients compared to 14% of rural 
patients).  
The rural patients were more likely to be non-user or low users of GP services while 
urban patients were more likely to be higher or extreme user of GP service than rural 
people as shown in Table 7. For specialist visits, the urban patients were more likely to be 
higher or extreme users of specialist service, while the rural residents were more to have 
used specialist services one times or 2 to 6 times, as shown in Table 7.  The percentage of 
subjects who were not hospitalized during the five-year follow-up was higher in urban 
than rural populations. The rural subjects had a higher hospitalization proportion than 
urban populations. Besides a higher proportion of hospitalization for rural subjects, they 
also tended to have longer stays in hospitals which ranged from one to thirty days as 
shown in Table 7. 
The percentage of diabetes complications and/ or comorbidities at the time of diagnosis 
was higher in rural (17.03%) compared to urban subjects (13.3%). Table 7 shows a higher 
percentage of mortality in rural residents (18.4%) compared to urban counterparts 
(15.8%). On the other hand, there was no significant difference between rural and urban 
patients who developed complications and/ or comorbidities during the five-year follow-
up. Approximately 7.05%, of rural patients developed one diabetic complication or 
comorbidity while 6.5% urban patients developed one complication or comorbidity 
during the study period. The respective percentage of two complications or comorbidities 
and more than two complications or comorbidities was 4.4% of rural residents compared 
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to 4.3% in urban patients and 5.95% of rural patients compared to 5.67% of urban 
residents, respectively. 
Table 7: Characteristics of Study Population According To the Place of Residence During 
the Study Period 
 RURAL % (N) 
(n= 9368) 
URBAN % (N) 
(n= 8428) 
Sex   
 
Men 48.9 (4,589) 51.4 (4,334) 
Women 51 (4,779) 48.6 (4,094) 
 
Age Group   
 20 - 39 7.98 (748) 9.4 (789) 
40 -49 14.3 (1,336) 16.4 (1,383) 
50 -59 24 (2,250) 25 (2,112) 
60 - 69 23.6 (2,215) 23.2 (1,955) 
≥ 70 30 (2,819) 25.97 (2,189) 
 
Visit with Family Physicians   
 -No visit (Nonuser) 8.5 (792) 4.7 (396) 
-One Visit  1.3 (121) 1.06 (90) 
-2–6 Visits (Regular) 42 (3,934) 40.4 (3,408) 
-7–12 (High User) 32.96 (3,088) 36.5 (3,077) 
-≥13 (Extreme User) 
 
15.3 (1,433) 17.3 (1,457) 
Visit with Specialists   
 -No visit  2.95 (277) 3.4 (284) 
-One Visit  3.6 (338) 2.97 (251) 
-2–6 Visits  70 (6,560) 63.6 (5,358) 
-7–12 visits 18.3 (1,719) 21.4 (1,803) 
-≥13 visits 5.05 (474) 8.68 (732) 
Hospitalization   
 NO 38.03 (3,563) 44.69 (3,767) 
 YES 
1 Time 3.8 (352) 2.96 (250) 
2-6 Times 58.2 (5,449) 52.3 (4,409) 
≥7 Times 
 
0.04 (4) 0.02 (2) 
Hospital Length Stay   
 
0 38.3 (3,592) 44.99 (3,792) 
1 Day 2.6 (246) 2.3 (219) 
2-6 Days 39.7 (3,715) 36.1 (3,045) 
7-14 Days 12.8 (1,198) 10.1 (853) 
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15-30 Days 4.89 (458) 4.2 (355) 
>30 Days 1.69 (159) 1.7 (164) 
 
Diabetes Diagnosis   
 
With Complications 17.06 (1,599) 13.3 (1,121) 
Without Complications 
 
82.9 (7,769) 86.69 (7,307) 
Mortality   
 
Alive 81.6 (7,647) 84.2 (7,095) 
Dead 18.4 (1,720) 15.8 (1,333) 
 
Complications and Comorbidities during 5 
years follow up 
  
 
No Complication 82.6 (7,740) 83.2 (7,015) 
One Complication 7.05 (661) 6.8 (571) 
Two Complications 4.4 (409) 4.3 (364) 
≥3 Complications 5.95 (558) 5.67 (478) 
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CHAPTER 5: INDIVIDUAL LEVEL ANALYSIS  
 
5.1) Logistic Regression 
 
5.1.1) Complications and Comorbidities at the Time of Diagnosis: 
The logistic regression analysis was performed to assess the association between 
complications and comorbidities at the time of diagnosis and place of residence (rural vs. 
urban). By using the continuous value of the A-R index, It was observed that people who 
were living in very remote/ less accessible areas were more likely to be diagnosed as 
complex cases, where diabetic complications and/ or comorbidities presented at the time 
of diagnosis. The likelihood of being diagnosed as complex case was 23% higher in rural 
areas than in urban (Odds Ratio(OR): 1.23, P<0.000, 95% CI: 1.19-1.28). When 
regression analysis was performed using postal code (dichotomous variable), a significant 
relationship was found where living in rural areas was associated with a high  ferequency  
of complex cases (OR: 1.13, P 0.000, 95% CI 1.03-1.25). Table 8 shows the adjusted 
regression model after adding age, sex and healthcare service visits as independent 
variables to the model.  
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Table 8: Logistic Regression for Complications and/ or Comorbidity at Diagnosis 
Variable Odds Ratio Standard 
Error 
P > z 95 % CI 
 
1) A-R Index 
2) Postal Code 
 
 
1.23 
1.13 
 
.022 
.06 
 
0.000 
.000 
 
1.19-1.28 
1.03-1.25 
Female .69 .689 0.000 .63-.76 
 
Age Group 
40-49 3.98 .91 0.000 2.54-6.23 
50-59 6.39 1.39 0.000 4.17-9.79 
60-69 
 
8.66 1.87 0.000 5.67-13.21 
≥70 15.21 3.26 0.000 10.01-23.11 
 
FM visits 
1 1.02 .21 0.911 .68-1.51 
2-6 .83 .067 0.02 .71-.97 
7-12 .43 .037 0.000 .36-.51 
≥13 
 
.45 .043 0.000 .37- .54 
 
SP visits 
1 .91 .212 0.692 .58-1.44 
2-6 .69 .117 0.031 .49-.97 
7-12 .82 .138 0.233 .59-1.13 
≥13 1.22 .216 0.263 .86-1.71 
 
Hospitalization 
1 74.72 594.177 0.000 154.41-3541.9 
2-6 531.97 423.211 0.000 112.3-2519.7 
≥7 2110.91 2588.55 0.000 192.4-
23155.86 
 
 
Length Stay 
1 .76 .299 0.493 .35-1.65 
2-6 1.4 .518 0.324 .70-2.92 
7-15 
16-30 
2.59 
2.59 
.945 
1.09 
0.009 
0.004 
1.26-5.31 
1.4-6.11 
>30 4.12 1.567 0.000 1.9-8.76 
The results within the enclosed rectangle are from two logistic regression models: 1) model using 
Postal Code and the variables included in the model to adjust  ( data was shown in the table. 2) 
The results from the second logistic regression model using A-R index using the same variables 
(data was not shown in the table)  
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                    5.1.2) Mortality 
Additionally, the logistic regression analysis was performed to assess the association 
between the mortality and place of residence among patients diagnosed with diabetes 
mellitus. Presence of complications/ comorbidities at the time of diagnosis (complex 
cases) was significantly associated with higher mortality (OR: 2.27, P < 0.0001, 95% CI: 
1.83 – 2.25). For the A-R index analysis, the results showed that the mortality was 1.11 
times higher in rural areas than in urban areas (OR: 1.11, P< 0.000, 95% CI: 1.07-1.16) 
and for the postal code analysis, the results showed that the mortality was 1.19 times 
higher in rural areas than in urban areas (OR: 1.19, P <0.000, 95% CI: 1.11-1.29). Table 
9 shows the adjusted regression model after adding age, sex and health care service visits 
as independent variables to the model.  
Table 9: Logistic Regression for Diabetes Mortality 
Mortality Odds Ratio Standard 
Error 
P > z 95 % CI 
 
1) A-R Index 
2) Postal Code 
 
 
1.11 
1.19 
 
.022 
.004 
 
0.000 
0.000 
 
1.07-1.16 
1.1-1.29 
Complications and 
comorbidity at 
diagnosis 
 
2.27 .111 0.000 1.83-2.25 
Female 
 
.82 .04 0.000 .73-.89 
 
  Age Group 
40-49 0.04 .007 0.011 .02-.05 
50-59 .06 .007 0.000 .05-.08 
60-69 .13 .009 0.000 .11-.15 
≥70 
 
.27 0.15 0.000 .24-.31 
 
 
FM visits 
1 1.73 .362 0.010 1.14-2.6 
2-6 1.33 .1139 0.001 1.12-1.58 
7-12 .55 .049 0.000 .46-.66 
 
50 
 
≥13 
 
.42 .042 0.000 .35-.52 
 
 
SP visits 
1 .85 .166 0.418 .58-1.25 
2-6 .65 .09 0.002 .49-.85 
7-12 .48 .07 0.000 .36-.64 
≥13 
 
.59 .09 0.001 .44-.82 
 
Hospitalization 
1 7.72 2.74 0.000 3.85-15.47 
2-6 6.63  2.25 0.000 3.42-12.87 
≥7 
 
16.14 16.7 0.006 2.24-116.1 
 
 
Length Stay 
1 .41 .155 0.018 .19-.86 
2-6 .72 .24 0.317 .37-1.38 
7-15 2.24 .769 0.017 1.15-4.3 
16-30 3.93 1.377 0.000 1.99-7.73 
>30 3.91 1.44 0.000 1.93-7.91 
The results in enclosed rectangle are from two logistic regression models: 1) model using Postal 
Code and the variables included in the model to adjust  ( data was shown in the table. 2) The 
results from the second logistic regression model using A-R index using the same variables (data 
was not shown in the table) 
            5.1.3) Diabetes Complications and Comorbidities During Study Period 
As shown in table 10 for the logistic regression analysis, the presence of complex cases 
was associated with increased development of complications and/ or comorbidities during 
the study period (OR: 3.73, P <0.0001, 95% CI: 3.34-4.17). For the A-R index and the 
postal code analysis, the results did not show any effect of remoteness areas on 
developing  complications and/ or comorbidities after five years follow-up (OR: 1.02, P> 
0.18, 95% CI: .99-1.06) and (OR: 1.05, P >0.29, 95% CI: .96-1.16), respectively. Table 
10 showed the adjusted regression model after adding age, sex and health care service 
visits as independent variables to the model.  
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Table 10: Logistic Regression for Diabetes Complications and Comorbidities during Study 
Period 
Complications  Odds Ratio Standard 
Error 
P > z 95 % CI 
 
1) A-R Index 
2) Postal Code 
 
 
 
 
1.02 
1.05 
 
.019 
.05 
 
0.18 
0.29 
 
.99-1.06 
.96-1.16 
 
Complications and 
comorbidity at 
diagnosis  
 
 
 
 
 
3.73 .212 0.000 3.337- 4.17 
Female 
 
 .635 .03 0.000 .58 - .69 
 
 
Age Group 
40-49  4.33 .812 0.000 2.99-6.25 
50-59  6.5 1.17 0.000 4.57-9.2 
60-69  7.39 1.32 0.000 5.2-10.5 
≥70 
 
 
 
5.29 .94 0.000 3.7-7.5 
 
 
FM visits 
1  .55 .157 0.036 .3-.96 
2-6  .93 .09 0.468 .76-1.12 
7-12  2.4 .24 0.000 2.01-2.94 
≥13 
 
 
 
3.5 .36 0.000 2.88-4.3 
 
SP visits 
1  .09 .032 0.000 .04-.18 
2-6  .36 .058 0.000 .26-.49 
7-12  .81 .13 0.196 .59-1.1 
≥13 
 
 
 
1.5 .25 0.014 1.08-2.1 
 
Hospitalization 
1  124.7 123.7 0.000 17.8-871.1 
2-6  117.4  115.8 0.000 16.9-811.7 
≥7 
 
 
 
215.6 325.2 0.000 11.2-4142.8 
 
 
  Length Stay 
1  6.8 4.9 0.007 1.6-27.7 
2-6  7.02 4.96 0.006 1.75-28.09 
7-15  7.3 5.2 0.005 1.8-29.3 
16-30  5.05 3.6 0.023 1.25-20.4 
>30  5.3 3.8 0.020 1.29-21.8 
The results in enclosed rectangle are from two logistic regression models: 1) model using Postal 
Code and the variables included in the model to adjust  ( data was shown in the table. 2) The 
results from the second logistic regression model using A-R index using the same variables (data 
was not shown in the table)  
 
 
52 
 
CHAPTER 6: SPATIAL AND COMMUNITY LEVEL 
ANALYSIS 
 
Although traditional interference and prevention efforts to reduce diabetes complications 
and comorbidities have focused on individual factors, a variety of community and 
environmental factors are involved in the development of chronic disease, which goes 
beyond the concept of personal choice
50
. In recent times, there has been a shift toward 
understanding diabetes diagnosis and outcomes (mortality, complications and 
comorbidities) from an ecological perspective
48, 49
. This wider perception provides 
opportunities to focus on the environmental and social impacts and to develop a more 
precise model of how population health factors might interact with the individual 
characteristics to produce variations in diabetes diagnosis and outcomes
50, 51
. 
Geographical methodologies provide opportunities to associate people with features of 
their local environment and to assess the spatial patterning of health outcomes such as 
diabetes diagnosis and outcomes. 
6.1) Diabetes Cumulative Incidence: 
 We used the ESRI ArcGIS software to create a map of diabetes cumulative incidence at 
the community level from 1998 to 2003, as shown in Figure 2.  
The map showed high cumulative incidence of diabetes in remote or less accessible areas 
while it started to be lower incidence with being inhabitant in urban or more accessible 
areas. 
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According to the accessibility remoteness index (A-R), the Northeast Avalon area was 
considered to be an accessible local area while its diabetes cumulative incidence was 
2.5%. Likewise, the Grand-Falls Point Leamington and Dear Lake Cormack were 
deemed to be accessible local areas and their cumulative diabetes incidence were 3.6% 
and 1.2% respectively. The Placentia Bay North West was seen as a remote (less 
accessible) area according to A-R index and its diabetes cumulative incidence was 12.2%. 
The Crabbes River area was one of the least accessible local areas in the province and 
resulted in an 8.3% incidence of diabetes. 
 
Figure 2: Diabetes Cumulative Incidence at Community Level 1998-2003 
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6.2) Diabetes Complications and Comorbidities at the Time of Diagnosis 
Figure 3 shows the distribution of diabetic patients diagnosed with complications and 
comorbidities from 1998 to 2003. The results showed a higher percentage of complex 
cases (diabetic patients diagnosed with comorbidities/complications) in remote areas with 
less accessibility as shown in the Belle Bay area with a proportion of 30.7% and the Strait 
of Belle Isle with 39.4%. Both areas were considered to be rural or remote areas 
according to the A-R index classification. However, the accessible local areas had a lower 
percentage of complex cases as indicated by the Northeast Avalon area (13%) and the 
Grand Falls Point Leamington area (8.6%).  
 
Figure 3: Distribution of Diabetic Patients Diagnosed With Complications/Comorbidities 1998-2003 
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6.2.1)  Spatial Analysis 
The Spatial Autocorrelation (Moran‘s I) 
The global Moran‘s I values (figure 4) for diabetic patients complications and/or 
comorbidities at the time of diagnosis showed a non-random pattern and positive spatial 
autocorrelation with a Moran‘s I of 0.05 and P- value< 0.0095. The z-score of 2.59 
indicated that there was less than 1% likelihood that this clustered pattern could be the 
result of randomness. 
 
Figure 4: Diagnosed With Complications/Comorbidities: Spatial Autocorrelation Results 
 
Anselin Local Moran‘s I 
Anselin local Moran‘s I (cluster – outlier) map (figure 5) for those diagnosed with 
complications and comorbidities demonstrated hot spots (High – High cluster) of 
complex cases in the Pinware River area with 48.9% (P<0.000), Strait of Belle Isle with 
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48.97% (P<0.000), Roddickton area with 27.8% (P<0.003) and Hermitage Bay with 33% 
(P<0.02). According to the A-R index classification, those areas were considered less 
accessible (remote). However, in the Goosebay area there was only 14% (P<0.013) of 
complex cases and the map showed it as a low – high outlier. 
 
Figure 5: Diagnosed With Complications/Comorbidities Anselin Local Moran’s I (Cluster-Outlier) Map 
 
6.2.2) Community Level Model 
            Model identification and fitness 
An iterative stepwise approach was used to determine the best-fitted model to predict 
diagnosis with complications. By adding and removing some variables and after 
conducting several trials, the model to predict the diagnosis with complications and 
comorbidities in terms of its relationships to explanatory variables included: the average 
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remoteness index score, the cumulative incidence at community level, the average age at 
time of diagnosis and the percentage of regular family medicine utilization at community 
level, as shown in Table 11, 12. 
By assessing model performance in Table 11, we determined the best fitted model we 
could derive through the previously mentioned explanatory variables. Our best fitted 
model had a Multiple R-Squared of 0.66 and Adjusted R- Squared of 0.64, where the 
adjusted R-Squared for model complexity (number of variables) as it related to the data 
and the model (explanatory variables modeled using linear regression) and explained 
approximately 64 percent of the variation in the dependent variable (complications and 
comorbidities at the time of diagnosis). 
Both the Joint F-Statistic and Joint Wald Statistic are measures of overall model 
statistical significance and were measured to be 35.63 and 92.23 respectively with a p-
value (probability) smaller than 0.001 which indicated a statistically significant model. 
The Koenker (BP) Statistic (Koenker's studentized Bruesch-Pagan statistic) is a tool to 
detect whether the explanatory variables in the model have a reliable relationship to the 
dependent variable both in geographic space and in data space. The Koenker p-value 
reveals how likely it is that the associations being modeled are constant across the entire 
study area. It was measured 16.6 with a p-value (probability) smaller than 0.001, which 
indicated statistically significant and the relationships did vary across the study area and 
were, therefore, nonstationary. 
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 The Jarque-Bera statistic was 2.19 with a p-value (probability) larger than 0.001 for a 
95 percent confidence level, meaning the residuals were normally distributed, which 
indicated that this model was not biased. 
Table 11: Ordinary Least Squares Regression & Residual Spatial Autocorrelation Results – 
Diagnosis with Complications 
Diagnostic Name Diagnostic Value 
AICc 495.12 
R
2 
0.66 
Adjusted R
2
 0.64 
Joint F-Statistic 35.63* 
Wald Statistic 92.23* 
Koenker (Breusch-Pagan) Statistic 16.61* 
Jarque-Bera Statistic 2.19
NS
 
*Significant (<0.001)              
 
NS
Not Significant 
Over and under predictions for an accurately identified regression model were randomly 
distributed to examine the model residuals. As shown in figure 6, the over-prediction 
(>2.5 standard deviations) and under-prediction areas (<-2.5 standard deviation) were not 
clustered, which provided evidence for a good model for predictions with no missing 
crucial variables. On the other hand, Figure 7 showed spatial autocorrelation results for 
the residuals with Moran‘s Index 0.013 and P-value= 0.2667, which were not statistically 
significant indicating a tendency toward randomness. Given a Z score of 1.11, the pattern 
did not appear to be significantly different from the pattern of randomness. 
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Figure 6: Ordinary Least Squares Regression Map – Diagnosis with Complications 
 
 
Figure 7: Ordinary Least Squares Regression & Residual Spatial Autocorrelation Results – 
Diagnosis with Complications 
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Ordinary least squares regression model for complications at the time of diagnosis 
Table 12 shows a positive relationship between complications at the time of diagnosis 
and the average remoteness index score (coefficient 18.09, P< 0.014) as well as the 
average age at the time of diagnosis (coefficient 1.63, P< 0.000) at the community level. 
There was an increase in the percentage of complications at the time of diagnosis, which 
was associated with both of increasing the remoteness scores (living in very remote (rural) 
areas) and increasing average age at diagnosis. Also, there was a negative relationship 
between the percentage of complications at the time of diagnosis and the following 
indicators: cumulative incidence of diabetes at the community level (coefficient -0.64, P< 
0.046) and percentage of regular family physician visits in the community (coefficient -
0.25, P< 0.000). A high percentage of regular family physician visits of low cumulative 
incidence was associated with a low percentage of complications at diagnosis at the 
community level.  
Table 12: Ordinary Least Squares Regression Model– Diagnosis with Complications 
Variable Coefficient Standard Error T Statistics Probability 
Intercept 
-74.05 14.41 -5.14 
0.000 
 
Average Remoteness 
Index Score 
18.09 7.22 2.51 0.014 
Cumulative 
Incidence of diabetes 
at Community Level 
-0.64 0.31 -2.03 0.046 
Average Age at 
Diagnosis 
1.63 0.22 7.47 0.000 
Percentage of 
Regular Visit with 
Family Physicians  
-0.25 0.07 -3.51 0.000 
Diagnosed with Complications/Comorbidities = -74 + 18 Remoteness Index - 0.64 Cumulative 
Incidence + 1.63 Age at Diagnosis - 0.25 Regular Visit with Family Physician 
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6.3) Mortality Proportion for Diabetic Patients During The Five-Year 
Study Period 
Figure 8 shows the distribution of mortality among diabetic patients during the five-year 
study period. There was a higher percentage of mortality in remote areas with less 
accessibility as exemplified by the following local areas: Strait of Belle Isle area (33.3%), 
Buchans area (31.8%), Bay d‘Espoir area (28.8%) and Roddick-ton area (27.2%) of 
mortality  percentage. These local areas with high percentage of mortality were deemed 
to be remote or rural according to the A-R index classification. With that in mind, the 
accessible local areas had lower percentage of complex cases as indicated by the 
Northeast Avalon area (15.2%) and Grand Falls Point Leamington areas (17.2%).  
 
Figure 8: Distribution of Mortality for Diabetic Patients during 5 Year Study Period 
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6.3.1)  Spatial Analysis 
The Spatial Autocorrelation (Moran‘s I) 
The spatial autocorrelation model (figure 9) for mortality during the five-year study 
period showed clustered values and positive spatial autocorrelation with Moran‘s I = 
0.0556 and P- value< 0.0038. The z-score of 2.89 indicated there was less than 1% 
likelihood that this clustered pattern could be the result of random. 
 
Figure 9: Mortality during Five Year Study Period: Spatial Autocorrelation Results 
 
Anselin Local Moran‘s I 
Anselin local Moran‘s I (cluster – outlier) map for mortality during the five years showed 
hot spots (High – High cluster) of mortality in the following areas: the Pinware River area 
with 26% (P<0.034), the Strait of Belle Isle with 33.3% (P<0.012) and the combination 
area of Catalina area, Trinity Bay and Black Head Bay with 25 - 40% (P<0.003) 
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mortality. According to the A-R index classification, those areas were considered to be 
less accessible (remote) areas. The Buchans area which had a 32% (P<0.039) mortality 
and Labrador North which had a 30% (P<0.001) mortality were classified as being high - 
low outliers, while the Terrence Ville area was found to be in a low – low cluster with a 9% 
(P<0.039) mortality. (Figure 10) 
 
Figure 10: Patient Mortality Anselin Local Moran’s I (Cluster-Outlier) Map 
 
6.3.2) Community Level Model 
Model identification and fitness 
An iterative stepwise approach was used to determine the best-fitted model for predicting 
diabetes mortality. By adding and removing variables and after conducting several trials 
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the best fitted model to predict diabetes mortality probability in terms of its relationships 
to explanatory variables included: average remoteness index score, percentage of 
complications and comorbidities at the time of diagnosis at the community level, the 
average age at diagnosis and the percentage of hospitalization at the community level. 
(Table 13, 14) 
By assessing model performance (Table 13), the best fitted resulted in a Multiple R-
Squared of 0.61 which represented the proportion of variation in the dependent variable 
explained by the model and Adjusted R- Squared of 0.59 which explained 
approximately 59 percent of the variation in the dependent variable (diabetic mortality). 
Both the Joint F-Statistic and Joint Wald Statistic measured 28.46 and 94.74 
respectively with a p-value (probability) smaller than 0.001, which indicated a 
statistically significant model. 
The Koenker (BP) Statistic (Koenker's studentized Bruesch-Pagan statistic) was 
measured 10.28 with a p-value (probability) smaller than 0.001, which indicated 
statistically significant and the relationships did vary across the study area and were, 
therefore, nonstationary. 
 The Jarque-Bera statistic was 4.67 with a p-value (probability) larger than 0.001 for a 
95 percent confidence level, meaning the residuals were normally distributed, which 
indicated that this model was not biased.  
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Table 13: Ordinary Least Squares Regression & Residual Spatial Autocorrelation Results – 
Mortality 
Diagnostic Name Diagnostic Value 
AICc 449.69 
R
2 
0.61 
Adjusted R
2
 0.59 
Joint F-Statistic 28.46* 
Wald Statistic 94.74* 
Koenker (Breusch-Pagan) Statistic 10.28* 
Jarque-Bera Statistic 4.67
NS
 
*Significant (<0.001)           
NS 
Not Significant 
Over and under predictions for an appropriately identified regression model was 
randomly distributed for examining the model residuals. As shown in figure 11, the over-
prediction (>2.5 standard deviations) and under-prediction areas (<-2.5 standard 
deviation) which indicated that it was not a good model for diabetes mortality 
predictions. Additionally, figure 12, showed spatial autocorrelation results for the 
residuals with Moran‘s Index I = 0.0725 and P-value< 0.0003, which indicated a 
tendency toward clustering and presented a non-random spatial pattern. The z-score of 
3.59 indicated there was less than 1% likelihood that this clustered pattern could be the 
result of randomness. 
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Figure 11: Ordinary Least Squares Regression Map – Mortality 
 
Figure 12: Ordinary Least Squares Regression & Residual Spatial Autocorrelation Results 
– Mortality 
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Ordinary least squares regression model for mortality after five -year follow up 
Table 14 shows, positive relationships between the diabetic mortality and both 
complications at the time of diagnosis (coefficient 0.18, P< 0.046) and the average age at 
the time of diagnosis (coefficient 0.94, P< 0.000) at the community level. There was no 
significant association between mortality proportion and both the average remoteness 
index score (coefficient 3.53, P= 0.531) and percentage of hospitalization at the 
community level (coefficient 0.21, P= 0.091).  
Table 14: Ordinary Least Squares Regression & Residual Spatial Autocorrelation Results – 
Mortality 
Variable Coefficient Standard Error T-Statistics Probability 
Intercept 
-43.57 12.11 -3.60 
0.001 
 
Average 
Remoteness Index 
Score 
3.53 5.62 0.62 0.531 
Percentage of 
Complications at 
time diagnosis at 
the Community 
Level 
0.18 0.09 2.02 0.046 
Average Age at 
Diagnosis 
0.94 0.21 4.52 0.000 
Percentage of 
Hospitalization at 
Community Level  
0.21 0.12 1.71 0.091 
 
6.4) Diabetic Complications and Comorbidities During the Study Period 
Figure 13 showed the distribution of diabetic patients that developed complications and 
comorbidities during the five-year study period and illustrated a higher percentage of 
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complications and comorbidities in remote areas, as indicated by local areas such as the 
Hermitage Bay area (25.5%), the Belle Bay area which (27%) and the Hawke‘s Bay Port 
Au Choix area (23.7%). These local areas were all classified as being remote or rural 
areas according to the A-R index classification. More accessible local areas had lower 
percnetages of patients developing complications and/or comorbidities during the study 
period, as indicated by the Northeast Avalon area (17%) and the Grand Falls Point 
Leamington area (13.5%). 
 
Figure 13: Distribution of Diabetic Patients That Developed Complications during Five 
Years Study Period 
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6.4.1)  Spatial Analysis 
The Spatial Autocorrelation (Moran‘s I) 
The spatial autocorrelation model (figure 14) which analyzed complications and/or 
comorbidities during the five-year study period showed a low and non-significant 
Moran‘s I index (Moran‘s I= 0.0088 and P- value= 0.3617). Given the Z-score of 0.19, 
the pattern did not appear to be significantly different from the pattern of randomness. 
The result from the spatial analysis showed that there was no spatial autocorrelation 
between diabetes complications and comorbidities and its associated spatial features 
(Local Areas) during the study period.  
 
Figure 14: Complications/Comorbidities during Five Year Study Period: Spatial 
Autocorrelation Results 
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6.4.2) Community Level Model 
We did  not perform any further geospatial analysis or OLS regression model as there 
was no spatial autocorrelation between diabetes complications and comorbidities and its 
associated spatial features (Local Areas) during the study period, according to the Global 
Moran‘s I model. 
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CHAPTER 7: DISCUSSION AND CONCLUSION 
This thesis aimed to assess the presence of disparities between rural and urban areas and 
to analyze the effect of geographic variation on diabetes diagnosis and outcomes 
(mortality, comorbidities and/or complications) in adults age 20 and older in NL after a 
five-year follow-up. This thesis illustrated the impact of rural-urban difference in 
demographic factors (sex and age) and health care utilization on diabetes outcomes 
factors (visits with specialists, family physicians, and hospitalization). This chapter 
initiates with an overview of the study results and how they compare to the current body 
of rural – urban disparities in diabetes research. A summary of the present study‘s 
strengths, limitations, implications, and conclusions are described. 
7.1)  Overview of The Findings 
This study focused on diabetes diagnosis and outcomes (complications, comorbidities, 
and mortality) but from a geographical aspect (rural and urban areas). The first question 
which the study tried to answer was: in adults age 20 years and older in NL, does where 
people live (rural vs. urban) affect the probability of complex cases (patients with 
complications and comorbidities at the time of diabetes diagnosis)? The second question 
was: in adults age 20 and older in NL, does where people live (rural vs. urban) affect their 
likelihood of death& developing complications/ co-morbidities and death after the 
diagnosis of diabetes? 
According to the individual level analysis, spatial and community level analysis, a 
positive relationship existed between complications and/or comorbidities at the time of 
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diagnosis and where one lived: people who lived in remote/ less accessible areas in NL 
were more likely to be diagnosed as a complex patient [OR: 1.23, P<0.000, 95% CI: 
1.19-1.28). Higher percentage of complex cases  in remote areas with less accessibility 
(30 – 50%) comparing to (8 -10%) of complex cases in accessible areas. Remote/less 
accessible areas mean increase distance from community services and accessibility to 
health care services like hospital, clinics or laboratories.The early detection of diabetes 
can result in timely treatment and the prevention of complications.  These results agree 
with what others found. For example, Roche et al. concluded that males diagnosed late 
with diabetes were more likely to live in a rural area
16. O‘Connor et al. found that the 
rural locations had the higher prevalence of diabetes and CVD, which aggravated the 
well-established lack of primary care providers in rural areas and also to more difficulty 
obtaining health insurance and longer distances to reach health care services
29
.  
After adjustment, the models for some crucial variables showed significant relationships 
between complex diagnosis and the different age groups and the number visits to the 
family physician. This finding agrees with the study from South Carolina, which 
concluded rural areas have less adequate care including physician visits which 
subsequently affect frequency of hospitalization for diabetic complications
19
. An 
American study by Salanitro et al
53
 of rural primary care practices showed that physician-
level performance was significantly related to patients‘ age and insulin use as well as 
difficulties with self-testing and keeping appointments. This study also concluded that 
rural patients confront barriers in self-testing and appointment keeping.   
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Our second hypothesis was that diabetes outcomes (complications, mortality) in urban 
areas were different from the outcomes in rural areas among adults aged 20 years and 
older five years after getting diagnosed with diabetes mellitus in NL. The logistic 
regression model, spatial and community level analysis didn‘t find any significant 
association between complications and/ or comorbidities during the five-year study 
period and living in remote or rural areas (OR: 1.02, P> 0.18, 95% CI: .988-1.06). After 
adjustment the models for some crucial variables, we observed that a diabetic patient who 
was diagnosed as a complex case was more likely to develop more complications and/ or 
comorbidities during the five-year follow-up. Complications and/ or comorbidities 
through the five-year follow-up were higher among the patients aged 60 to 69 years old 
and also with more visits for a family physician.  
A study by Krishna et al.
54
 disclosed that rural diabetes self-management education 
(DSME) in the rural areas of Pennsylvania is an underused service and lower than one-
half of this patients reported receiving any diabetes education. The lack of this service in 
the rural communities caused a dramatic increase in myocardial infarctions, 
microvascular disease, and death
54
. The American Diabetes Association recommends 
diabetes preventive care practices of an annual eye examination, annual foot examination 
by a health professional, and HbA1c testing at least twice a year
55, 56
. The other studies 
showed that residing in rural areas had increased the barriers to receiving these 
recommended care for eye and foot examinations
56, 57
. So, examining the diabetic 
complications and/or comorbidities may give a significant association with a rurality by 
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adding other explanatory variables or it might need a longer period of follow-up during 
the study. 
The logistic regression model showed that mortality increased in those patients who were 
diagnosed as a complex case, and these complex cases were more likely to live in remote/ 
less accessible areas. So the individual level model showed that there was a high risk of 
mortality in rural and remote areas (OR: 1.11, P< 0.000, 95% CI: 1.07-1.16). The spatial 
and the community level analysis showed positive spatial autocorrelation between spatial 
features and mortality with high clustering of mortality in rural and remote areas. The 
best-fitted OLS model for mortality prediction found a positive relationship between 
mortality and both complications at the time of diagnosis and the average age of diabetic 
patients. However, the standardized residuals from the OLS model for mortality were 
spatially autocorrelated and therefore globally miss-specified so that mortality could be 
predicted at the local level but not globally. These results agree with the study by Roche 
et al. who found a late diabetes diagnosis was positively associated with CVD mortality 
and CVD and have a longer length of hospital stay for females
16
.  A study, published in 
2011
58
, on the variances between rural and urban health in Canada, found that those who 
lived in rural or remote regions had a higher mortality percentage than urban residents
58
. 
The mortality proprotion related to diabetes appeared to be a greater worry for women 
living in rural area than women in urban regions
58
. The main causes for the differences 
detected in rural Canadians were the limited access to health care and maintenance 
programs compared to Canadians living in urban places and absence of early diagnosis, 
where it was known that treatment will have better outcomes
58,59,60,61
. 
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Hill criteria, suggested by English epidemiologist Sir Austin Bradford Hill
61
, are a group 
of criteria to provide evidence of a causal relationship between a cause (in this study 
place of residence) and its effect (in this study diabetes diagnosis and outcomes). This 
study addresses some of these criteria:  Strength of association: the odds ratio of 1.2 and 
the coefficient of 18 in this study propose a causal effect between living in rural areas and 
getting diagnosis as a complex case. Consistency: both the individual and community 
level analysis showed a high association between remote/less accessible areas and the 
prevalence of complex cases. Furthermore, previous studies listed a significant 
relationship between living in a rural area and developing complications or comorbidities 
at the time of diagnosis
16,21,24,28,29
. Studies also showed that people who were living in 
remote areas were more likely to die
16, 18, 52
. Consistent findings observed by different 
investigators in different places with different samples strengthened the likelihood of an 
effect of the remote/ less accessible areas on complex cases and mortality.  Temporality: a 
cohort study using the geospatial technique to identify the place of residence at the time 
of diagnosis was also supportive of a causal relationship. Analogy:  other studies for 
different chronic diseases showed the place of residence as an influential factor in 
diagnosis and outcomes
16, 22, 57, 58, 59,62
. Coherence: there was consistency between 
epidemiological and geospatial findings showing an increase the likelihood of the 
complex cases and the mortality in remote/ less accessible areas. 
Biological gradient: the accessibility remoteness index score ranged from highly 
accessible to extremely remote, the individual and community level models showed that 
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increase in remoteness leads to a greater incidence of complex cases and the mortality, 
which agreed with the criteria of a biological gradient.  
7.2)  Strength and Limitations  
To our knowledge, this is the first study in NL using a GIS approach to identify 
differences between rural and urban regions and to define whether these variances affect 
diabetes diagnosis and outcomes. Additionally, using a large population-based database 
and performing both individual and community level analyses, was a cost-effectiveness 
approach to enhance the accuracy of study findings and to improve the generalizability of 
these conclusions. 
The study does have some limitation, however. First, this was a retrospective cohort 
study using secondary data, so it is not as reliable as a prospective study. In our study, we 
used the CCDSS diabetes case definition, so we were not capable of distinguishing 
between type 1 and type 2 diabetes; however, this is not likely to have a major effect on 
the results as the study population included adult only, most of the adults have type 2 
diabetes
15
.  
The CCDSS diabetes case definition depends on the physician claims data and hospital 
discharge data. In NL, one-third of the physicians in the province are paid on a salary 
basis, who is not obliged to submit medical claims. Consequently, the sample of diabetes 
cases might be less than the exact and the real number of incident cases.  
This secondary analysis is representative of complications and comorbidities condition 
recorded in our database. In reality, hospital discharge data and physician billing are 
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limited in the representation of some disease state including obesity, dyslipidemia and the 
disease condition which may be diagnosed by allied health practitioner such as 
retinopathy
16
. 
We were restricted to a cut-off point of one year when identifying complex cases as the 
data was available on a yearly basis not per month. Several studies empathized that 
comorbidities or complications that developed in individuals with diabetes could be 
extended from definite to very broad (6 months–2 years) before/after diagnosis16, 21.  
Additionally, secondary data does not provide information on all factors influencing 
diabetes diagnosis and outcomes including socioeconomic status, patient educations, 
patient moving or income. So, future studies can be designed using a prospective cohort 
study approach which can test more explanatory variables related to diabetes 
comorbidities. 
The community level analysis is prone to an ecological fallacy, but it is less likely to be 
an issue in this study. Similar findings were obtained using individual-level modeling, 
community-level modeling and geospatial visualization. 
Lastly, this study used the place of habitation at the beginning of the study period but the 
movement from an urban to a rural region and vice versa through the 5-year study period 
could have occurred. 
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7.3)  Conclusions 
Our findings indicated that at the individual level, living in a rural area affected the 
likelihood of complications and/ or comorbidities at the time of diagnosis. The individual 
level analysis showed that living in rural areas did not affect the likelihood of the 
complications and/ or comorbidities through the five-year follow-up; however, it showed 
that people who were living in a remote places were more likely to die. At the community 
level, the results of each model demonstrated the importance of proper conceptualization 
of geography and how a person‘s environment could influence their health outcomes. We 
did find that remoteness/ accessibility affected the likelihood of a complex case detection. 
While the diabetic patients who were living in a remote/ less accessible area were more 
likely to die at the local level, the OLS model was miss-specified and A-R index was not 
significant. So, the mortality could be predicted at the local level but not globally. 
Besides, the geospatial analysis did not show that residing in a remote area had any effect 
on complication and comorbidities through the five-year follow-up.  
 People in remote rural locations often face many challenges in access to healthcare 
services resulting in under diagnoses, and poorer health outcomes. Identifying potential 
individual risk factors and rural/urban factors affecting diabetes in NL could help inform 
intervention strategies to decrease the risk of diabetes and its complications in at-risk 
populations. Different aspects of statistical, geographical and epidemiological analysis 
were used in this study, which can help to develop a new methodology for using the 
medico-administrative data in NL and getting more accurate and significant results which 
help decision-makers better  understand the geographic variations in diabetes diagnosis 
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and management. By demonstrating diabetes diagnosis and outcomes in a geographic 
context, this project could help in allocating resources more efficiently to improve 
healthcare services including screening, diagnosis, and controlling services for diabetes. 
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APPENDIX  
 
Table 15    Summary of Findings in Studies Relevant to Rural/Urban Difference in Diabetes Diagnosis and Outcomes 
Study Country Study 
Population 
Study 
Sample 
Size 
Study 
Design 
Rural / 
Urban 
definition 
Complications 
and morbidities 
at diagnosis 
Complications Mortality 
Kevin et al, 
2012 
South 
Carolina, 
Columbia 
 
 
 
 
 
 
At least 1 
hospitalization 
during the year  
21275 Retrospective 
cohort study 
Rural was defined 
using the 2003 
Urban Influence 
Codes (UICs). 
UICs of rurality 
were classified as 
―urban‖ while all 
other UICs were 
classified as 
―rural.‖ Analysis 
across levels of 
rurality used 3 
groups: 
―metropolitan 
rural‖ (UICs 3, 5, 
and 8); ―small 
adjacent rural‖ 
(UICs 4, 6, and 7); 
and ―remote rural‖ 
(UICs 9, 10, 11, 
and 12). 
 20% discharged from a 
hospitalization had a 
subsequent 
readmission within 30 
days, with only 10% of 
these being intended 
readmissions. 
Residents of remote 
rural counties were 
also less likely to have 
a readmission (OR 
0.74, 0.57-0.95) 
Follow-up physician 
visit within 30 days 
were lower in rural 
inhabitants, 12.9% 
rural compared to 
14.9% urban. 
 
O'Connor et 
al, 2012 
United State. 
 
 
 
 
respondents 
using data from 
the US Centers 
for Disease 
Control and 
Prevention's 
(CDC's) 2008 
Behavioral Risk 
214,000 Cross-sectional 
study 
Respondents were 
categorized by 
metropolitan 
statistical area 
(MSA). 
Respondents 
living in an urban 
area with 50,000 
 Prevalence rates of 
diabetes and CVD 
were 8.6% (P = 0.001) 
and 38.8% (P < 0.001) 
higher among 
population living in 
rural areas compared 
with urban areas, 
 
86 
 
 
 
 
 
 
Factor 
Surveillance 
System 
or more 
inhabitants were 
designated as 
‗urban‘, whereas 
respondents living 
outside of an MSA 
were designated as 
‗rural.‘  
respectively. 
After controlling for 
risk factors, the 
prevalence of diabetes 
was lower among 
respondents living in 
rural areas [prevalence 
odds ratio 
(POR) = 0.94, 
P = 0.032], but the 
prevalence of coronary 
heart disease was 
higher (POR = 1.09, 
P = 0.011). 
Dos Santos et 
al, 2013 
Brazil. 
 
 
 
 
 
 
 
Elderly 
individuals with 
self-reported 
DM. 
Aged 60 years or 
more. 
271 elderly 
individuals 
from urban 
areas and 104 
from rural 
areas 
observational and 
cross-sectional 
household survey 
studies 
The population 
sample analyzed 
by the Center for 
Research in 
Community 
Health of the 
Triangulo Mineiro 
Federal University 
was used to define 
the urban 
population. 
The mean number of 
morbidities within the 
elderly urban population 
(μ = 8.57) was 
significantly higher than 
that of the rural 
population (μ = 7.2). 
Females were more 
prevalent in both the 
urban (69%) and rural 
(65.4%) areas. 
The elderly urban 
population reported 
more vision problems 
(β = 1.875; p = 0.019), 
instances of poor 
circulation (β = 3.189; 
p < 0.001) and heart 
problems (β = 2.271; p 
= 0.001) compared to 
the rural population. 
 
 
the elderly 
individuals who 
lived in the 
rural area had 
significantly 
lower QoL 
scores than 
those of the 
urban area in 
the sensory 
abilities (β = -
0.243; p 
Hye Y. et al, 
2010 
Korea 
 
 
 
 
adults >30 year 
of age  
from urban 
and rural districts 
 
 
 
1,060 from 
urban (189 
males and 331 
females) and 
rural districts 
(219 males 
and 321 
females). 
Prospective 
Cohort study 
The characteristics 
of rural life were 
defined to 
represent a 
livelihood related 
to agriculture or 
agrarian activities, 
while the 
livelihood of 
urban dwellers 
was primarily 
office work. 
Higher prevalence of 
T2DM in an urban 
population (14.5 %) 
compared to a rural 
population (8.6%) in 
Korea. 
The serum HDL-C 
level and monthly 
income were 
significantly higher in 
the urban than rural 
population (3.95 vs 
3.74 mM/L). 
Systolic blood pressure 
is high in both 
populations. 
 
 
Vanasse A et 
al, 2010 
Quebec 
(Canada 
1- patients newly 
hospitalized for a 
myocardial 
infarction (MI) 
1- The 
atheroscleroti
c cohort 
included a 
retrospective 
population-based 
cohort studies 
According to The 
Statistical Area 
Classification 
(SAC) there are 
 For atherosclerosis and 
diabetes, the adjusted 
rates of 
morbidity were 
No difference 
between rural 
and urban areas 
in the mortality 
87 
 
2- patients who 
had suffered a 
fragility fracture 
(FF) 
3-Incident cases 
of diabetic (DB) 
patients.  
total of 44 
806 patients 
2- The cohort 
of 
patients with 
FFs included 
a total of 64 
540 
individuals 
3- A total of 
71 857 
patients were 
newly 
diagnosed 
with diabetes 
between 2001 
and 2002. 
two 
categories of 
urban areas 
depending on the 
size of the urban 
core population: 
Census 
Metropolitan 
Areas (CMA) or 
metropolitan 
areas, with a 
population of at 
least 100 000, and 
Census 
Agglomerations 
(CA) or small 
towns, with a 
population 
between 10 000 
and 99 999 
significantly higher in 
non-metropolitan 
areas than in 
metropolitan areas with 
the highest rates found 
in remote regions 
rates is 
observed across 
all three chronic 
diseases 
Attard et al, 
2012 
China. 
 
 
 
 
 
 
18– 90 years old. 7741 adults Cohort study Urbanisation was 
measured using an 
urbanisation index 
based on 
household- and 
community-level 
data representing 
12 features of the 
community 
environment.  
 
High vs low urbanisation 
was associated with 
approximate twofold 
higher diabetes prevalence 
(men OR 2.02, 95% CI 
1.47, 2.78; women OR 
1.94, 95% CI 1.35, 2.79). 
The prevalence of 
undiagnosed diabetes did 
not differ by high vs low 
urbanisation level (men 
OR 1.25, 95% CI 0.84, 
1.85; women OR 1.38, 
95% CI 0.88, 2.17). 
  
Cheryl et al, 
2011 
United State 
 
 
 
 
 
veterans with 
type 2 diabetes 
determined 
according to US 
census-based 
metropolitan 
statistical area 
10,570 Cohort study The Office of 
Management and 
Budget (OMB) 
defines ―rural‖ as 
residing in a non-
metropolitan 
statistical area 
(MSA). 
A lower proportion of 
rural patients received 
screening and preventive 
clinical services than 
urban patients, such as 
lipid profiles (74% versus 
50%), eye examinations 
(18% versus 6%), micro 
albumin screening (32% 
versus 4%), aspirin 
therapy (39% versus 18%) 
and vaccinations (74% 
Rural veterans had less 
access to care, higher 
susceptibility to travel 
barriers, lower health-
related quality of life, 
and a higher 
prevalence and poorer 
control of physical 
health comorbidities. 
 
88 
 
 
 
versus 11%) 
Dyck et al, 
2013 
Saskatchewan 
 
 
 
 
Male and Female 
aged 18 years or 
older who lived 
on an identified 
farm/non-farm 
location 
8208  prospective cohort 
study 
rural dwelling – 
residence on a 
farm or non-farm 
location (including 
town and self-
described acreage) 
Residence on farms had 
significantly lower 
diabetes prevalence than 
those living in non-farm 
locations. 
Diabetes prevalence in 
nonfarm location is 7.3% 
compared to 5.1% among 
those living on farms. 
 
Cardiovascular 
disorders exhibited 
odds ratios (ORs) of 
3.01 (hardening of the 
arteries) to 5.21 (high 
blood pressure) among 
people with diabetes 
compared to others, 
while tuberculosis also 
demonstrated a strong 
relationship. Cancer 
and chronic lung 
disorders displayed 
less striking but still 
largely significant 
associations with 
diabetes. Diagnosed 
sleep apnea and related 
symptoms 
demonstrated 
particularly significant 
associations with 
diabetes. 
 
Nathan et al, 
2010 
United States 
 
 
 
 
 
18 and older self-
reporting a 
diagnosis of 
diabetes  
29,501 a cross-sectional 
analysis 
Definitions of 
rural were based 
on the 2003 Urban 
Influence Codes 
(UICs) from the 
United States 
Department of 
Agriculture 
Economic 
Research Service. 
Rural counties 
vary in size, and 
may contain 
modest urbanized 
areas of less than 
50,000 
populations. 
A lower proportion of 
rural than urban persons 
with diabetes reported a 
dilated eye examination 
(69.1 vs. 72.4%; P = 
0.005) or a foot 
examination in the past 
year (70.6 vs. 73.7%; P = 
0.016). 
a greater proportion of 
rural than urban 
persons reported 
diabetic retinopathy 
(25.8 vs. 22.0%; P = 
0.007) and having a 
foot sore taking more 
than four weeks to heal 
(13.2 vs. 11.2%; P = 
0.036). 
 
Madonna  et 
al, 2013 
Newfoundlan
d and 
individuals aged 
25 years or older 
73,783 population-based 
retrospective 
urban place of 
residence was 
A late-diagnosed diabetes 
patient would have 
Diabetes was 
positively associated 
both males and 
females with 
89 
 
Labrador 
 
 
 
 
 
 
 
 
cohort study defined as an area 
with $5,000 
inhabitants, 
whereas a rural 
place of residence 
was defined as an 
area with ,5,000 
inhabitants 
comorbidities related to 
diabetes at the time of 
diagnosis with diabetes-
related comorbidities 
within 6 months before or 
after diagnosis. 
Males and females with 
late diagnoses were 
significantly older at the 
time of diagnosis than 
those with early diagnoses 
(P< 0.01). 
Survival time for both 
males and females with 
early diagnoses was 
significantly longer than 
that of those with late 
diagnoses (P < 0.01). 
During the study period, 
males and females with 
late diabetes diagnoses 
were more likely to be 
hospitalized (P < 0.01) 
and have a longer length 
of hospital stay compared 
with those with early 
diagnoses (P < 0.01). 
CVD hospitalizations 
(2.57 [2.24–2.94]) for 
females, and the risk 
was significantly 
higher compared with 
their male counterparts 
(1.59 [1.51–1.69] and 
1.92 [1.72–2.14]). 
A late diabetes 
diagnosis was 
positively associated 
with CVD mortality 
(HR 6.54 [95% CI 
4.80– 8.91]) and CVD 
hospitalizations (5.22 
[4.31–6.33]) for 
females, and the risk 
was significantly 
higher compared with 
their male counterparts 
(3.44 [2.47–4.79] and 
3.33 [2.80–3.95]). 
diabetes had an 
increased risk 
of dying of all 
causes and 
being 
hospitalized for 
CVD and AMI 
when compared 
with males and 
females without 
diabetes. 
Diabetes was 
positively 
associated with 
all-cause 
mortality (HR 
1.85 [95% CI 
1.74– 1.96]) 
Madonna  et 
al, 2014 
Newfoundlan
d and 
Labrador 
 
 
 
 
 
 
individuals aged 
25 years 
7101 Cross-sectional 
study 
Urban region of 
residence was 
defined in the 
CCHS as an area 
with a population 
concentration of 
1000 or more and 
a population 
density of 400 or 
more per square 
kilometer based on 
census counts 
Males diagnosed late with 
diabetes were more likely 
to live in a rural area 
compared to early 
diagnosed males (P < 
0.01), whereas no 
difference was found for 
females. Males with late 
diagnoses were more 
likely to be 
overweight/obese 
compared to early 
diagnosed males (P < 
0.01), while no difference 
was found for females. On 
the other hand, females 
with a late diabetes 
diagnosis were more 
likely to be physically 
Living in a rural area 
(HR, 1.47; 95% CI, 
1.01-2.15), receiving 
social assistance (HR, 
2.80; 95% CI, 1.52-
5.15), having poor self-
perceived health (HR, 
2.06; 95% CI, 1.32-
3.21), and considering 
most days stressful 
(HR, 1.45; 95% CI, 
1.01-2.10) were 
positively associated 
with diabetes for 
females. 
 
90 
 
inactive compared to 
females diagnosed early 
(P < 0.01). For males, no 
factors were significantly 
associated with an early or 
late diabetes diagnosis. 
However, for females, 
having a low education 
(OR, 0.33; 95% CI, 0.11-
0.99) was inversely 
associated with a late 
diabetes diagnosis 
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